EP2144996A1 - Gene et proteine de regulation du carbone et de l'azote et modulation de ceux-ci - Google Patents

Gene et proteine de regulation du carbone et de l'azote et modulation de ceux-ci

Info

Publication number
EP2144996A1
EP2144996A1 EP08733744A EP08733744A EP2144996A1 EP 2144996 A1 EP2144996 A1 EP 2144996A1 EP 08733744 A EP08733744 A EP 08733744A EP 08733744 A EP08733744 A EP 08733744A EP 2144996 A1 EP2144996 A1 EP 2144996A1
Authority
EP
European Patent Office
Prior art keywords
sequence
plant
nucleotide sequence
nucleic acid
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08733744A
Other languages
German (de)
English (en)
Other versions
EP2144996A4 (fr
Inventor
Steven Rothstein
Yong-Mei Bi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Guelph
Original Assignee
University of Guelph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Guelph filed Critical University of Guelph
Publication of EP2144996A1 publication Critical patent/EP2144996A1/fr
Publication of EP2144996A4 publication Critical patent/EP2144996A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8237—Externally regulated expression systems
    • C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5097—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving plant cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Definitions

  • the present invention relates to methods of modulating agronomic traits in plants by modulating the expression of a GATA transcription factor in the plant cells.
  • the GATA transcription factor is isolated from Oryza sativa and is important in chlorophyll synthesis, sugar accumulation, nitrogen status, stress tolerance and grain yield, and ultimately, can modulate nitrogen uptake and overall carbon metabolism.
  • a number of highly-efficient approaches are available to assist identification of genes playing key roles in expression of agronomically- important traits. These include genetics, genomics, bioinformatics, and functional genomics. Genetics is the scientific study of the mechanisms of inheritance. By identifying mutations that alter the pathway or response of interest, classical (or forward) genetics can help to identify the genes involved in these pathways or responses. For example, a mutant with enhanced susceptibility to disease may identify an important component of the plant signal transduction pathway leading from pathogen recognition to disease resistance. Genetics is also the central component in improvement of germplasm by breeding. Through molecular and phenotypic analysis of genetic crosses, loci controlling traits of interest can be mapped and followed in subsequent generations. Knowledge of the genes underlying phenotypic variation between crop accessions can enable development of markers that greatly increase efficiency of the germplasm improvement process, as well as open avenues for discovery of additional superior alleles.
  • Genomics is the system-level study of an organism's genome, including genes and corresponding gene products - RNA and proteins.
  • genomic approaches have provided large datasets of sequence information from diverse plant species, including full-length and partial cDNA sequences, and the complete genomic sequence of a model plant species, Arabidopsis thaliana.
  • the first draft sequence of a crop plant's genome, that of rice (Oryza sativa) has also become available.
  • Availability of a whole genome sequence makes possible the development of tools for system-level study of other molecular complements, such as arrays and chips for use in determining the complement of expressed genes in an organism under specific conditions.
  • Bioinformatics approaches interface directly with first-level genomic datasets in allowing for processing to uncover sequences of interest by annotative or other means.
  • bioinformatics can often identify homologs of a gene product of interest.
  • Very similar homologs eg. > -90% amino acid identity over the entire length of the protein
  • Functional genomics can be defined as the assignment of function to genes and their products.
  • Functional genomics draws from genetics, genomics and bioinformatics to derive a path toward identifying genes important in a particular pathway or response of interest.
  • Expression analysis uses high density DNA microarrays (often derived from genomic-scale organismal sequencing) to monitor the mRNA expression of thousands of genes in a single experiment. Experimental treatments can include those eliciting a response of interest, such as the disease resistance response in plants infected with a pathogen.
  • mRNA expression levels can be monitored in distinct tissues over a developmental time course, or in mutants affected in a response of interest.
  • Proteomics can also help to assign function, by assaying the expression and post-translational modifications of hundreds of proteins in a single experiment.
  • Protein-protein interactions can also help to assign proteins to a given pathway or response, by identifying proteins that interact with known components of the pathway or response.
  • protein- protein interactions are often studied using large-scale yeast two-hybrid assays.
  • Another approach to assigning gene function is to express the corresponding protein in a heterologous host, for example the bacterium Escherichia coli, followed by purification and enzymatic assays.
  • Demonstration of the ability of a gene-of-interest to control a given trait may be derived, for example, from experimental testing in plant species of interest.
  • the generation and analysis of plants transgenic for a gene of interest can be used for plant functional genomics, with several advantages.
  • the gene can often be both overexpressed and underexpressed ("knocked out"), thereby increasing the chances of observing a phenotype linking the gene to a pathway or response of interest.
  • Two aspects of transgenic functional genomics help lend a high level of confidence to functional assignment by this approach.
  • phenotypic observations are carried out - A - in the context of the living plant.
  • Second, the range of phenotypes observed can be checked and correlated with observed expression levels of the introduced transgene.
  • Transgenic functional genomics is especially valuable in improved cultivar development. Only genes that function in a pathway or response of interest, and that in addition are able to confer a desired trait- based phenotype, are promoted as candidate genes for crop improvement efforts. In some cases, transgenic lines developed for functional genomics studies can be directly utilized in initial stages of product development.
  • Another approach towards plant functional genomics involves first identifying plant lines with mutations in specific genes of interest, followed by phenotypic evaluation of the consequences of such gene knockouts on the trait under study. Such an approach reveals genes essential for expression of specific traits.
  • Genes identified through functional genomics can be directly employed in efforts towards germplasm improvement by transgenic means, as described above, or used to develop markers for identification of tracking of alleles-of-interest in mapping and breeding populations. Knowledge of such genes may also enable construction of superior alleles non-existent in nature, by any of a number of molecular methods. Rapid increases in yield over the last 80 years in row crops have been due in roughly equal measure to improved genetics and improved agronomic practices. In particular, in a crop like maize, the combination of high yielding hybrids and the use of large amounts of nitrogen fertilizer have under ideal conditions allowed for yields of greater than 440bu/acre.
  • Nitrogen use efficiency can be defined in several ways, although the simplest is yield/N supplied. There are two stages in this process: first, the amount of available nitrogen that is taken up, stored and assimilated into amino acids and other important nitrogenous compounds; second, the proportion of nitrogen that is partitioned to the seed, resulting in final yield.
  • a variety of field studies have been performed on various agriculturally important crops to study this problem (Lawlor DW et al 2001 in Lea PJ, Morot- Gaudry JF, eds. Plant Nitrogen. Berlin: Springer- Verlag 343-367; Lafitte HR and Edmeades GO 1994 Field Crops Res 39, 15-25; Lawlor DW 2002 J Exp Bot.
  • Nitrate is the major form of available nitrogen in the field and there is an extensive body of literature on genes involved in nitrate uptake and reduction (Forde BG 2000 Biochimica et Biophysica Acta 1465, 219-235; Howitt SM and Udvardi MK 2000 Biochimica et Biophysica Acta 1465, 152- 170; Stitt M et al 2002 J Exp Bot. 53, 959-70) as well as on genes involved in other aspects of nitrogen metabolism (Lea PJ, Morot-Gaudry JF, eds. 2001 Plant Nitrogen. Berlin: Springer- Verlag; Morot-Gaudry JF 2001 Nitrogen assimilation by plants Science Publishers Inc. NH, US).
  • Plants can sense levels of carbon and nitrogen metabolites and accordingly adjust growth and development.
  • the perception mechanisms are complex regulatory networks that control gene expression to accommodate constant changes of nutrient-dependent cellular activities. Possession of a sugar-sensing mechanism enables plants to turn off photosynthesis when C- skeletons are abundant.
  • the N-sensing mechanism enables plants to turn off nitrate uptake and reduction when levels of reduced or organic N are high (Coruzzi, G.M. & Zhou, L. (2001) Curr Opin Plant Biol. 4, 247-53).
  • Hexokinases are an important control point for glucose metabolism. They not only catalyze the phosphorylation of glucose but also function as a glucose sensor to interrelate nutrient, light and hormone signaling networks for controlling growth and development in response to the changing environment (Jang, J., Leon, P, Zhou, L. & Sheen, J.
  • N signals and sensing pathways exist as well in plants. Plants have mechanisms to sense nitrate, the major form of nitrogen fertilizer, as a signal for inorganic N status as well as to sense metabolites derived from nitrate as signals for reduced or organic N status.
  • Nitrate reductase (NR) and nitrite reductase (NiR) are the first two enzymes in the nitrate reduction process and their expression can be stimulated by the presence of nitrate and modulated by other physiological factors including some nitrogenous compounds, sucrose, light and hormone (Forde, B. G. (2000) Biochimica et Biophysica Acta 1465, 219-235; Howitt, S. M. & Udvardi, M. K.
  • GATA motifs have been identified in the regulatory regions of many light responsive genes (Arguello-Astorga, G. & Herrera-Estrella, L. (1998) Annu Rev Plant Physiol Plant MoI Biol 49, 525-555), including many genes involved in or relating to photosynthesis such as the RBCS, CAB (chlorophyll A/B binding protein) and GAP (glyceraldehyde-3-phosphate dehydrogenase) (Terzaghi, W.B. & Cashmore, A.R. (1995) Annu Rev Plant Physiol Plant MoI Biol 46, 445-474; Koch, K.E. (1996) Carbohydrate-modulated gene expression in plants.
  • GATA transcription factor genes Some known trans-acting regulatory proteins that globally regulate genes in N metabolism are GATA transcription factor genes.
  • yeast four global nitrogen regulatory factors GLN3, NIL1 , NIL2 and DAL80 are DNA-binding proteins that contain a single GATA zinc finger, recognizing the consensus motif GATA (Hofman-Bang, J. (1999) MoI Biotech 12, 35-73).
  • the inventors have isolated a new GATA transcription factor from rice, termed OsGATA11 , which is an ortholog of the At4g26150 gene from Arabidopsis.
  • the At4g26150 gene is a GNC paralog in the phylogenetic tree of the 30 Arabidopsis GATA transcription factor genes (Reyes, J. C 1 Muro- Pastor, M.I. & Florencio, F.J. (2004) Plant Physiol. 134, 1718-1732) and was found to have overlapping function with GNC.
  • the inventors have determined that the expression of the OsGATA11 gene regulates chlorophyll synthesis, seed yield and stress response to low nitrogen levels.
  • over-expression of the OsGATA11 gene can have a positive effect on nitrate and amino acid levels, as well as on sugar accumulation.
  • Loss-of-function mutant plants in the OsGATA11 gene resulted in reduced chlorophyll levels, reduced amino acid and protein levels, as well as reduced sugar accumulation.
  • transgenic rice plants silencing the OsGATA11 gene via RNAi as well as transgenic plants over-expressing the rice gene, were created.
  • the plants transformed with the OsGATA11 gene had increased chlorophyll levels and increased seed yield and had an improved stress response to low nitrogen levels. Plants grown under high N experienced stress after being transferred from the growth room to the greenhouse and the transgenic plants over-expressing OsGATA11 responded much better to the stress.
  • Sugars are central regulators of many vital processes in photosynthetic plants, such as photosynthesis and carbon and nitrogen metabolism. This regulation is achieved by regulating gene expression to either activate or repress genes involved. The mechanisms by which sugars control gene expression are not understood well.
  • the GATA transcription factor disclosed here is involved in regulating sugar levels including sucrose, glucose and fructose levels, as well as regulating nitrate, amino acid and protein levels. Increased expression of this gene can produce plants with increased yield, particularly as the manipulation of sugar signaling pathways can lead to increased photosynthesis and increased nitrogen assimilation and alter source-sink relationships in seeds, tubes, roots and other storage organs.
  • the present invention relates to a method of modulating a characteristic in a plant or plant cell comprising modulating expression of a GATA transcription factor gene in the plant or plant cell.
  • the invention provides a method of modulating a characteristic in a plant or plant cell comprising modulating expression of a GATA transcription factor in the plant or plant cell, wherein the GATA transcription factor comprises:
  • the expression of the GATA transcription factor gene is modulated by administering, to the cell, an effective amount of an agent that can modulate the expression levels of a GATA transcription factor gene in the plant cell.
  • the agent enhances the expression levels of a GATA transcription factor gene in the plant or plant cell.
  • the agent decreases the expression levels of a GATA transcription factor gene in the plant or plant cell.
  • the characteristic to be modulated in the plant may be any agronomic trait of interest.
  • the characteristic is any that is affected by nitrogen, carbon and/or sulfur metabolism, biosynthesis of lipids, perception of nutrients, nutritional adaptation, electron transport and/or membrane associated energy conservation.
  • the characteristic is selected from one or more of nitrogen utilization, yield, cell growth, reproduction, photosynthesis, nitrogen assimilation, disease resistance, differentiation, signal transduction, gene regulation, abiotic stress tolerance and nutritional composition.
  • the characteristic is selected from the group consisting of chlorophyll synthesis, seed yield, stress tolerance, nitrate levels, amino acid levels and sugar accumulation.
  • the modulated characteristic is an increase or improvement in one or more of nitrogen utilization, yield, cell growth, reproduction, photosynthesis, nitrogen assimilation, disease resistance, differentiation, signal transduction, gene regulation abiotic stress tolerance and nutritional composition.
  • the modulated characteristic is an increase or improvement in chlorophyll synthesis, seed yield, stress tolerance, nitrate levels, amino acid levels and sugar accumulation.
  • the modulated characteristic is a decrease or reduction in chlorophyll synthesis, seed yield, stress tolerance, nitrate levels, amino acid levels and sugar accumulation.
  • the present invention relates to a method of improving nitrogen utilization in a plant or plant cell comprising enhancing expression of a GATA transcription factor gene in the plant or plant cell. Improving nitrogen utilization in a plant will allow for reduce amounts of nitrogen fertilizer to applied to the plant with a concomitant reduction in costs to the farmer and cost to the environment since nitrate pollution is a major problem in many agricultural areas contributing significantly to the degradation of both fresh water and marine environments.
  • the plant or plant cell may be from any plant wherein one wishes to modulate a characteristic.
  • the plant cell is a dicot, a gymnosperm or a monocot. In one embodiment, the dicot is selected from the group consisting of soybean, tobacco or cotton.
  • the monocot is selected from maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, milo, flax, gramma grass, Tripsacum sp. and teosite.
  • the agent that enhances the expression levels of a GATA transcription factor gene in the plant cell comprises a nucleic acid molecule encoding a GATA transcription factor.
  • the agent that can modulate the expression levels of a GATA transcription factor gene in a plant cell comprises:
  • the agent enhances the expression levels of a GATA transcription factor and comprises a nucleic acid molecule encoding a GATA transcription factor.
  • the nucleic acid molecule comprises the sequence of the
  • the nucleic acid molecule comprises a sequence that hybridizes under medium stringency conditions to the
  • the nucleic acid molecule is derived from the nucleotide sequence of the GATA transcription factor of SEQ ID NO:1 or a functional fragment thereof.
  • NO:1 has a nucleotide sequence comprising codons specific for expression in plants.
  • the agent inhibits or decreases the expression levels of a GATA transcription factor and comprises a nucleic acid molecule that inhibits expression of the GATA transcription factor.
  • the nucleic acid molecule is an interfering RNA molecule used for RNA interference (RNAi).
  • the nucleic acid molecule is an anti-sense molecule.
  • the agent that can modulate the expression levels of a GATA transcription factor gene in a plant cell comprises:
  • the agent when the agent is a nucleic acid sequence, the nucleic acid sequence is expressed in a specific location or tissue of the plant.
  • the location or tissue is for example, but not limited to, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf and/or flower. In an alternative embodiment, the location or tissue is a seed.
  • Embodiments of the present invention also relate to use of a shuffled nucleic acid molecule for modulating a characteristic in a plant cell, said shuffled nucleic acid molecule containing a plurality of nucleotide sequence fragments, wherein at least one of the fragments encodes a GATA transcription factor and wherein at least two of the plurality of sequence fragments are in an order, from 5' to 3' which is not an order in which the plurality of fragments naturally occur in a nucleic acid.
  • all of the fragments in a shuffled nucleic acid molecule containing a plurality of nucleotide sequence fragments are from a single gene.
  • the plurality of fragments originate from at least two different genes.
  • the shuffled nucleic acid is operably linked to a promoter sequence.
  • Another more specific embodiment is a use of a chimeric polynucleotide for modulating a characteristic in a plant cell, said chimeric polynucleotide including a promoter sequence operably linked to the shuffled nucleic acid.
  • the shuffled nucleic acid is contained within a host cell.
  • the fragment encoding a GATA transcription factor consists of or comprises:
  • the isolated nucleic acid encoding a GATA transcription factor consists of or comprises:
  • a recombinant vector for modulating a characteristic in a plant cell comprising an expression cassette including a promoter sequence operably linked to an isolated nucleic acid encoding a GATA transcription factor.
  • the isolated nucleic acid encoding a GATA transcription factor consists of or comprises:
  • (f) a nucleotide sequence that is the reverse complement of (a), (b), (C) or (d). Also encompassed are uses of plant cells, which contain expression cassettes, according to the present disclosure, and uses of plants, containing these plant cells.
  • the expression cassette is expressed throughout the plant. In another embodiment, the expression cassette is expressed in a specific location or tissue of a plant. In a specific embodiment, the location or tissue may be, for example, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower. In an alternative specific embodiment, the location or tissue is a seed.
  • Embodiments of the present invention also provide the use of seed and isolated product from plants for modulating a characteristic in a plant cell, which contain an expression cassette including a promoter sequence operably linked to an isolated nucleic acid encoding a GATA transcription factor gene according to the present invention.
  • the expression vector includes one or more elements such as, for example, but not limited to, a promoter-enhancer sequence, a selection marker sequence, an origin of replication, an epitope- tag encoding sequence, or an affinity purification-tag encoding sequence.
  • the promoter-enhancer sequence may be, for example, the CaMV 35S promoter, the CaMV 19S promoter, the tobacco PR- la promoter, ubiquitin and the phaseolin promoter.
  • the promoter is operable in plants, and more specifically, a constitutive or inducible promoter.
  • the selection marker sequence encodes an antibiotic resistance gene.
  • the epitope-tag sequence encodes V5, the peptide Phe-His-His- Thr-Thr, hemagglutinin, or glutathione-S-transferase.
  • the affinity purification-tag sequence encodes a polyamino acid sequence or a polypeptide.
  • the polyamino acid sequence is polyhistidine.
  • the polypeptide is chitin binding domain or glutathione-S-transferase.
  • the affinity purification-tag sequence comprises an intein encoding sequence.
  • the expression vector is a eukaryotic expression vector or a prokaryotic expression vector.
  • the eukaryotic expression vector includes a tissue-specific promoter. More specifically, the expression vector is operable in plants.
  • Embodiments of the present invention also relate to a plant modified by a method that includes introducing into a plant a nucleic acid where the nucleic acid is expressible in the plant in an amount effective to effect the modificatio ⁇ .
  • the modification can be an increase or decrease in the one or more traits of interest.
  • the modification may include overexpression, underexpression, antisense modulation, sense suppression, inducible expression, inducible repression, or inducible modulation of a gene.
  • the modification involved an increase or improvement in the trait of interest, for example, nitrogen utilization.
  • Embodiments of the present invention provide nucleotide and amino acid sequences isolated from Arabidopsis thaliana. Particularly, the present invention relates to a nitrogen-regulated GATA transcription factor gene required for sugar sensing.
  • the sequence having substantial similarity to the nucleotide sequence of SEQ ID NO:1 , a fragment or domain thereof, is from a plant.
  • the plant is a dicot.
  • the dicot is selected from the group consisting of soybean, tobacco or cotton.
  • the plant is a gymnosperm.
  • the plant is a monocot.
  • the monocot is a cereal.
  • the cereal may be, for example, maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, milo, flax, gramma grass, Tripsacum sp., or teosinte.
  • the nucleic acid is expressed in a specific location or tissue of a plant.
  • the location or tissue is for example, but not limited to, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower.
  • the location or tissue is a seed.
  • the nucleic acid encodes a polypeptide involved in a function such as, for example, but not limited to, carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • the isolated nucleic acid comprises or consists of a nucleotide sequence capable of hybridizing to a nucleotide sequence listed in SEQ ID NO:1 or a fragment or domain thereof.
  • hybridization allows the sequence to form a duplex at medium or high stringency.
  • Embodiments of the present invention also encompass a nucleotide sequence complementary to a nucleotide sequence of SEQ ID NO:1 or a fragment or domain thereof.
  • Embodiments of the present invention further encompass a nucleotide sequence complementary to a nucleotide sequence that has substantial similarity or is capable of hybridizing to a nucleotide sequence of SEQ ID NO:1 or a fragment or domain thereof.
  • the nucleotide sequence having substantial similarity is an allelic variant of the nucleotide sequence of SEQ ID NO:1 a fragment or domain thereof.
  • the sequence having substantial similarity is a naturally occurring variant.
  • the sequence having substantial similarity is a polymorphic variant of the nucleotide sequence of SEQ ID NO:1 or a fragment or domain thereof.
  • the isolated nucleic acid contains a plurality of regions having the nucleotide sequence of SEQ ID NO:1 or exon or domain thereof.
  • the isolated nucleic acid contains a polypeptide-encoding sequence.
  • the polypeptide-encoding sequence contains a 20 base pair nucleotide portion identical in sequence to a consecutive 20 base pair nucleotide portion of a nucleic acid sequence of SEQ ID NO:1.
  • the polypeptide contains a polypeptide sequence of SEQ ID NO:2, or a fragment thereof.
  • the polypeptide is a plant polypeptide.
  • the plant is a dicot.
  • the plant is a gymnosperm.
  • the plant is a monocot.
  • the monocot is a cereal.
  • the cereal may be, for example, maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, miloflax, gramma grass, Tripsacum, and teosinte.
  • the polypeptide is expressed throughout the plant.
  • the polypeptide is expressed in a specific location or tissue of a plant.
  • the location or tissue may be, for example, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower.
  • the location or tissue is a seed.
  • the sequence of the isolated nucleic acid encodes a polypeptide useful for generating an antibody having immunoreactivity against a polypeptide encoded by a nucleotide sequence of SEQ ID NO:2, or fragment or domain thereof.
  • the sequence having substantial similarity contains a deletion or insertion of at least one nucleotide.
  • the deletion or insertion is of less than about thirty nucleotides. In a most specific embodiment, the deletion or insertion is of less than about five nucleotides.
  • the sequence of the isolated nucleic acid having substantial similarity comprises or consists of a substitution in at least one codon. In a specific embodiment, the substitution is conservative.
  • embodiments of the present invention also relate to an isolated nucleic acid molecule comprising or consisting of a nucleotide sequence, its complement, or its reverse complement, encoding a polypeptide including:
  • the polypeptide having substantial similarity is an allelic variant of a polypeptide sequence of SEQ ID NO:2, or a fragment, domain, repeat or chimera thereof.
  • the isolated nucleic acid includes a plurality of regions from the polypeptide sequence encoded by a nucleotide sequence identical to or having substantial similarity to a nucleotide sequence of SEQ ID NO:1 , or fragment or domain thereof, or a sequence complementary thereto.
  • the polypeptide is a polypeptide sequence of SEQ ID NO:2. In another specific embodiment, the polypeptide is a functional fragment or domain. In yet another specific embodiment, the polypeptide is a chimera, where the chimera may include functional protein domains, including domains, repeats, post-translational modification sites, or other features. In a more specific embodiment, the polypeptide is a plant polypeptide. In a more specific embodiment, the plant is a dicot. In a more specific embodiment, the plant is a gymnosperm. In a more specific embodiment, the plant is a monocot. In a more specific embodiment, the monocot is a cereal.
  • the cereal may be, for example, maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, milo, flax, gramma grass, Tripsacum, and teosinte.
  • the polypeptide is expressed in a specific location or tissue of a plant.
  • the location or tissue may be, for example, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower.
  • the location or tissue is a seed.
  • the polypeptide sequence encoded by a nucleotide sequence having substantial similarity to a nucleotide sequence of SEQ ID NO:1 or a fragment or domain thereof or a sequence complementary thereto includes a deletion or insertion of at least one nucleotide.
  • the deletion or insertion is of less than about thirty nucleotides. In a most specific embodiment, the deletion or insertion is of less than about five nucleotides.
  • the polypeptide sequence encoded by a nucleotide sequence having substantial similarity to a nucleotide sequence of SEQ ID NO:1 , or a fragment or domain thereof or a sequence complementary thereto includes a substitution of at least one codon. In a more specific embodiment, the substitution is conservative.
  • the polypeptide sequences having substantial similarity to the polypeptide sequence of SEQ ID NO:2 or a fragment, domain, repeat, or chimeras thereof includes a deletion or insertion of at least one amino acid. In a specific embodiment, the polypeptide sequences having substantial similarity to the polypeptide sequence of SEQ ID NO:2 or a fragment, domain, repeat, or chimeras thereof includes a substitution of at least one amino acid.
  • Embodiments of the present invention also relate to a shuffled nucleic acid containing a plurality of nucleotide sequence fragments, wherein at least one of the fragments corresponds to a region of a nucleotide sequence of SEQ ID NO:1 and wherein at least two of the plurality of sequence fragments are in an order, from 5' to 3' which is not an order in which the plurality of fragments naturally occur in a nucleic acid.
  • all of the fragments in a shuffled nucleic acid containing a plurality of nucleotide sequence fragments are from a single gene.
  • the plurality of fragments originates from at least two different genes.
  • the shuffled nucleic acid is operably linked to a promoter sequence.
  • a chimeric polynucleotide including a promoter sequence operably linked to the shuffled nucleic acid.
  • the shuffled nucleic acid is contained within a host cell.
  • Embodiments of the present invention also contemplate an expression cassette including a promoter sequence operably linked to an isolated nucleic acid containing a nucleotide sequence including: a) a nucleotide sequence of SEQ ID NO:1 or a fragment or domain thereof;
  • a recombinant vector comprising an expression cassette according to embodiments of the present invention.
  • plant cells which contain expression cassettes, according to the present disclosure, and plants, containing these plant cells.
  • the plant is a dicot.
  • the dicot is selected from the group consisting of soybean, tobacco or cotton.
  • the plant is a gymnosperm.
  • the plant is a monocot.
  • the monocot is a cereal.
  • the cereal may be, for example, maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, milo, flax, gramma grass, Tripsacum and teosinte.
  • the expression cassette is expressed throughout the plant. In another embodiment, the expression cassette is expressed in a specific location or tissue of a plant. In a specific embodiment, the location or tissue may be, for example, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower. In an alternative specific embodiment, the location or tissue is a seed.
  • the expression cassette is involved in a function such as, for example, but not limited to, carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • the chimeric polypeptide is involved in a function such as, nitrogen utilization, abiotic stress tolerance, enhanced yield, disease resistance and/or nutritional composition.
  • the plant contains a modification to a phenotype or measurable characteristic of the plant, the modification being attributable to the expression of at least one gene contained in the expression cassette.
  • the modification may be, for example, carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • Embodiments of the present invention also provide seed and isolated product from plants which contain an expression cassette including a promoter sequence operably linked to an isolated nucleic acid containing a nucleotide sequence including: (a) a nucleotide sequence of SEQ ID NO:1or a fragment or domain thereof;
  • the isolated product includes an enzyme, a nutritional protein, a structural protein, an amino acid, a lipid, a fatty acid, a polysaccharide, a sugar, an alcohol, an alkaloid, a carotenoid, a propanoid, a steroid, a pigment, a vitamin and a plant hormone.
  • Embodiments of the present invention also relate to isolated products produced by expression of an isolated nucleic acid containing a nucleotide sequence including: (a) a nucleotide sequence of SEQ ID NO:1 , or fragment or domain thereof;
  • the product is produced in a plant. In another specific embodiment, the product is produced in cell culture. In another specific embodiment, the product is produced in a cell-free system. In another specific embodiment, the product includes an enzyme, a nutritional protein, a structural protein, an amino acid, a lipid, a fatty acid, a polysaccharide, a sugar, an alcohol, an alkaloid, a carotenoid, a propanoid, a steroid, a pigment, a vitamin and a plant hormone.
  • the product is a polypeptide containing an amino acid sequence of SEQ ID NO:2.
  • the protein is an transcription factor.
  • Embodiments of the present invention further relate to an isolated polynucleotide including a nucleotide sequence of at least 10 bases, which sequence is identical, complementary, or substantially similar to a region of any sequence of SEQ ID NO:1 , and wherein the polynucleotide is adapted for any of numerous uses.
  • the polynucleotide is used as a chromosomal marker. In another specific embodiment, the polynucleotide is used as a marker for RFLP analysis. In another specific embodiment, the polynucleotide is used as a marker for quantitative trait linked breeding. In another specific embodiment, the polynucleotide is used as a marker for marker-assisted breeding. In another specific embodiment, the polynucleotide is used as a bait sequence in a two-hybrid system to identify sequence- encoding polypeptides interacting with the polypeptide encoded by the bait sequence. In another specific embodiment, the polynucleotide is used as a diagnostic indicator for genotyping or identifying an individual or population of individuals. In another specific embodiment, the polynucleotide is used for genetic analysis to identify boundaries of genes or exons.
  • the expression vector includes one or more elements such as, for example, but not limited to, a promoter-enhancer sequence, a selection marker sequence, an origin of replication, an epitope- tag encoding sequence, or an affinity purification-tag encoding sequence.
  • the promoter-enhancer sequence may be, for example, the CaMV 35S promoter, the CaMV 19S promoter, the tobacco PR- la promoter, ubiquitin and the phaseolin promoter.
  • the promoter is operable in plants, and more specifically, a constitutive or inducible promoter.
  • the selection marker sequence encodes an antibiotic resistance gene.
  • the epitope-tag sequence encodes V5, the peptide Phe-His-His- Thr-Thr, hemagglutinin, or glutathione-S-transferase.
  • the affinity purification-tag sequence encodes a polyamino acid sequence or a polypeptide.
  • the polyamino acid sequence is polyhistidine.
  • the polypeptide is chitin binding domain or glutathione-S-transferase.
  • the affinity purification-tag sequence comprises an intein encoding sequence.
  • the expression vector is a eukaryotic expression vector or a prokaryotic expression vector.
  • the eukaryotic expression vector includes a tissue-specific promoter. More specifically, the expression vector is operable in plants.
  • Embodiments of the present invention also relate to a cell comprising or consisting of a nucleic acid construct comprising an expression vector and a nucleic acid including a nucleic acid encoding a polypeptide as listed in SEQ ID NO:2, or a nucleic acid sequence listed in SEQ ID NO:1 , or a segment thereof, in combination with a heterologous sequence.
  • the cell is a bacterial cell, a fungal cell, a plant cell, or an animal cell. In a specific embodiment, the cell is a plant cell. In a more specific embodiment, the polypeptide is expressed in a specific location or tissue of a plant. In a most specific embodiment, the location or tissue may be, for example, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower. In an alternate most specific embodiment, the location or tissue is a seed.
  • the polypeptide is involved in a function such as, for example, carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • a function such as, for example, carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • polypeptides encoded by the isolated nucleic acid molecules of the present disclosure including a polypeptide containing a polypeptide sequence encoded by an isolated nucleic acid containing a nucleotide sequence including:
  • Embodiments of the present invention contemplate a polypeptide containing a polypeptide sequence encoded by an isolated nucleic acid which includes a shuffled nucleic acid containing a plurality of nucleotide sequence fragments, wherein at least one of the fragments corresponds to a region of a nucleotide sequence listed SEQ ID NO:1 , and wherein at least two of the plurality of sequence fragments are in an order, from 5' to 3' which is not an order in which the plurality of fragments naturally occur in a nucleic acid, or functional fragment thereof.
  • Embodiments of the present invention contemplate a polypeptide containing a polypeptide sequence encoded by an isolated polynucleotide containing a nucleotide sequence of at least 10 bases, which sequence is identical, complementary, or substantially similar to a region of any of sequences of SEQ ID NO:1 , or functional fragment thereof and wherein the polynucleotide is adapted for a use including:
  • Embodiments of the present invention also contemplate an isolated polypeptide containing a polypeptide sequence including:
  • a polypeptide sequence encoded by a nucleotide sequence identical to or having substantial similarity to a nucleotide sequence SEQ ID NO:1 , or an exon or domain thereof, or a sequence complementary thereto (d) a polypeptide sequence encoded by a nucleotide sequence capable of hybridizing under medium stringency conditions to a nucleotide sequence listed in SEQ ID NO:1 , or to a sequence complementary thereto; or
  • the substantial similarity is at least about 80% identity. In a most specific embodiment, the substantial similarity is at least about 95% identity. In a specific embodiment, the substantial similarity is at least three percent greater than the percent identity to the closest homologous sequence listed in any of the Sequence Listings.
  • the sequence having substantial similarity is from a plant.
  • the plant is a dicot.
  • the plant is a gymnosperm.
  • the plant is a monocot.
  • the monocot is a cereal.
  • the cereal may be, for example, maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, milo, flax, gramma grass, Tripsacum and teosinte.
  • the polypeptide is expressed in a specific location or tissue of a plant.
  • the location or tissue may be, for example, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower.
  • the location or tissue is a seed.
  • the polypeptide is involved in a function such as, for example, carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • hybridization of a polypeptide sequence encoded by a nucleotide sequence identical to or having substantial similarity to a nucleotide sequence listed in SEQ ID NO:1 , or an exon or domain thereof, or a sequence complementary thereto, or a polypeptide sequence encoded by a nucleotide sequence capable of hybridizing under medium stringency conditions to a nucleotide sequence listed SEQ ID NO:1 , or to a sequence complementary thereto allows the sequence to form a duplex at medium or high stringency.
  • a polypeptide having substantial similarity to a polypeptide sequence listed in SEQ ID NO:2, or exon or domain thereof is an allelic variant of the polypeptide sequence listed in SEQ ID NO:2.
  • a polypeptide having substantial similarity to a polypeptide sequence listed in SEQ ID NO:2, or exon or domain thereof is a naturally occurring variant of the polypeptide sequence listed in SEQ ID NO:2.
  • a polypeptide having substantial similarity to a polypeptide sequence listed in SEQ ID NO:2, or exon or domain thereof is a polymorphic variant of the polypeptide sequence listed in SEQ ID NO:2.
  • the sequence having substantial similarity contains a deletion or insertion of at least one amino acid.
  • the deletion or insertion is of less than about ten amino acids.
  • the deletion or insertion is of less than about three amino acids.
  • the sequence having substantial similarity encodes a substitution in at least one amino acid.
  • the modification comprises an altered characteristic in the plant, wherein the characteristic corresponds to the nucleic acid introduced into the plant.
  • the characteristic corresponds to carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • the modification includes an increased or decreased expression or accumulation of a product of the plant.
  • the product is a natural product of the plant.
  • the product is a new or altered product of the plant.
  • the product comprises a
  • Also encompassed within the presently disclosed invention is a method of producing a recombinant protein, comprising the steps of:
  • nucleic acid construct (a) growing recombinant cells comprising a nucleic acid construct under suitable growth conditions, the construct comprising an expression vector and a nucleic acid including: a nucleic acid encoding a protein as listed in SEQ ID NO:2, or a nucleic acid sequence listed in SEQ ID NO:1 , or segments thereof; and
  • Embodiments of the present invention provide a method of producing a recombinant protein in which the expression vector includes one or more elements including a promoter-enhancer sequence, a selection marker sequence, an origin of replication, an epitope-tag encoding sequence, and an affinity purification-tag encoding sequence.
  • the nucleic acid construct includes an epitope-tag encoding sequence and the isolating step includes use of an antibody specific for the epitope-tag.
  • the nucleic acid construct contains a polyamino acid encoding sequence and the isolating step includes use of a resin comprising a polyamino acid binding substance, specifically where the polyamino acid is polyhistidine and the polyamino binding resin is nickel- charged agarose resin.
  • the nucleic acid construct contains a polypeptide encoding sequence and the isolating step includes the use of a resin containing a polypeptide binding substance, specifically where the polypeptide is a chitin binding domain and the resin contains chitin-sepharose.
  • Embodiments of the present invention also relate to a plant modified by a method that includes introducing into a plant a nucleic acid where the nucleic acid is expressible in the plant in an amount effective to effect the modification.
  • the modification can be, for example, carbon, nitrogen and/or sulfur metabolism, nitrogen utilization, nitrogen assimilation, photosynthesis, signal transduction, cell growth, reproduction, disease resistance, abiotic stress tolerance, nutritional composition, gene regulation, and/or differentiation.
  • the modified plant has increased or decreased resistance to an herbicide, a stress, or a pathogen.
  • the modified plant has enhanced or diminished requirement for light, water, nitrogen, or trace elements.
  • the modified plant is enriched for an essential amino acid as a proportion of a protein fraction of the plant.
  • the protein fraction may be, for example, total seed protein, soluble protein, insoluble protein, water-extractable protein, and lipid-associated protein.
  • the modification may include overexpression, underexpression, antisense modulation, sense suppression, inducible expression, inducible repression, or inducible modulation of a gene.
  • the invention further relates to a seed from a modified plant or an isolated product of a modified plant, where the product may be an enzyme, a nutritional protein, a structural protein, an amino acid, a lipid, a fatty acid, a polysaccharide, a sugar, an alcohol, an alkaloid, a carotenoid, a propanoid, a steroid, a pigment, a vitamin and a plant hormone.
  • the product may be an enzyme, a nutritional protein, a structural protein, an amino acid, a lipid, a fatty acid, a polysaccharide, a sugar, an alcohol, an alkaloid, a carotenoid, a propanoid, a steroid, a pigment, a vitamin and a plant hormone.
  • Figure 1 and SEQ ID NO:1 shows the nucleic acid sequence of full length OsGATA11.
  • FIG. 1 shows the amino acid sequence of OsGATA11.
  • Figure 3 shows the alignment of the amino acid sequence of At4g26150 (SEQ ID NO:7) and its rice ortholog OsGATA11 (SEQ ID NO:2).
  • Figure 4A and B shows the phenotypes of the OsGATAH over- expressing plants.
  • Figure 5A and B shows the chlorophyll level affected by the expression of OsGA TA11 gene.
  • Figure 6A and B shows the seed yield of OsGATA11 over-expressing plants.
  • Figure 7 are pictures showing more resistant to stress in the OsGATAH over-expressing plants.
  • Figure 8 are graphs showing how sugar accumulation is affected by modulating the expression of OsGATA11 : 8A: glucose level; 8B: fructose levels; 8C: sucrose levels.
  • Figure 9 are graphs showing how nitrogen status are modulated in OsGATA11 transgenic plants: 9A: nitrate level; 9B: amino acid level; 9C: protein level.
  • Associated with / operatively linked refer to two nucleic acid sequences that are related physically or functionally.
  • a promoter or regulatory DNA sequence is said to be “associated with” a DNA sequence that codes for an RNA or a protein if the two sequences are operatively linked, or situated such that the regulator DNA sequence will affect the expression level of the coding or structural DNA sequence.
  • a “chimeric construct” is a recombinant nucleic acid sequence in which a promoter or regulatory nucleic acid sequence is operatively linked to, or associated with, a nucleic acid sequence that codes for an mRNA or which is expressed as a protein, such that the regulatory nucleic acid sequence is able to regulate transcription or expression of the associated nucleic acid sequence.
  • the regulatory nucleic acid sequence of the chimeric construct is not normally operatively linked to the associated nucleic acid sequence as found in nature.
  • a "co-factor” is a natural reactant, such as an organic molecule or a metal ion, required in an enzyme-catalyzed reaction.
  • a co-factor is e.g. NAD(P), riboflavin (including FAD and FMN), folate, molybdopterin, thiamin, biotin, lipoic acid, pantothenic acid and coenzyme A, S-adenosylmethionine, pyridoxal phosphate, ubiquinone, menaquinone.
  • a co-factor can be regenerated and reused.
  • a "coding sequence” is a nucleic acid sequence that is transcribed into RNA such as mRNA, rRNA, tRNA, snRNA, sense RNA or antisense RNA. Specifically the RNA is then translated in an organism to produce a protein.
  • Complementary refers to two nucleotide sequences that comprise antiparallel nucleotide sequences capable of pairing with one another upon formation of hydrogen bonds between the complementary base residues in the antiparallel nucleotide sequences.
  • Enzyme activity means herein the ability of an enzyme to catalyze the conversion of a substrate into a product.
  • a substrate for the enzyme comprises the natural substrate of the enzyme but also comprises analogues of the natural substrate, which can also be converted, by the enzyme into a product or into an analogue of a product. The activity of the enzyme is measured for example by determining the amount of product in the reaction after a certain period of time, or by determining the amount of substrate remaining in the reaction mixture after a certain period of time.
  • the activity of the enzyme is also measured by determining the amount of an unused co- factor of the reaction remaining in the reaction mixture after a certain period of time or by determining the amount of used co-factor in the reaction mixture after a certain period of time.
  • the activity of the enzyme is also measured by determining the amount of a donor of free energy or energy-rich molecule (e.g. ATP, phosphoenolpyruvate, acetyl phosphate or phosphocreatine) remaining in the reaction mixture after a certain period of time or by determining the amount of a used donor of free energy or energy-rich molecule (e.g. ADP, pyruvate, acetate or creatine) in the reaction mixture after a certain period of time.
  • a donor of free energy or energy-rich molecule e.g. ATP, phosphoenolpyruvate, acetyl phosphate or phosphocreatine
  • Expression cassette means a nucleic acid molecule capable of directing expression of a particular nucleotide sequence in an appropriate host cell, comprising a promoter operatively linked to the nucleotide sequence of interest which is operatively linked to termination signals. It also typically comprises sequences required for proper translation of the nucleotide sequence.
  • the coding region usually codes for a protein of interest but may also code for a functional RNA of interest, for example antisense RNA or a nontranslated RNA, in the sense or antisense direction.
  • the expression cassette comprising the nucleotide sequence of interest may be chimeric, meaning that at least one of its components is heterologous with respect to at least one of its other components.
  • the expression cassette may also be one that is naturally occurring but has been obtained in a recombinant form useful for heterologous expression. Typically, however, the expression cassette is heterologous with respect to the host, i.e., the particular DNA sequence of the expression cassette does not occur naturally in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation event.
  • the expression of the nucleotide sequence in the expression cassette may be under the control of a constitutive promoter or of an inducible promoter that initiates transcription only when the host cell is exposed to some particular external stimulus. In the case of a multicellular organism, such as a plant, the promoter can also be specific to a particular tissue or organ or stage of development.
  • telomere a segment of DNA associated with a biological function.
  • genes include coding sequences and/or the regulatory sequences required for their expression.
  • Genes also include nonexpressed DNA segments that, for example, form recognition sequences for other proteins.
  • Genes can be obtained from a variety of sources, including cloning from a source of interest or synthesizing from known or predicted sequence information, and may include sequences designed to have desired parameters.
  • Heterologous/exogenous when used herein to refer to a nucleic acid sequence (e.g. a DNA sequence) or a gene, refer to a sequence that originates from a source foreign to the particular host cell or, if from the same source, is modified from its original form.
  • a heterologous gene in a host cell includes a gene that is endogenous to the particular host cell but has been modified through, for example, the use of DNA shuffling.
  • the terms also include non-naturally occurring multiple copies of a naturally occurring DNA sequence.
  • the terms refer to a DNA segment that is foreign or heterologous to the cell, or homologous to the cell but in a position within the host cell nucleic acid in which the element is not ordinarily found. Exogenous DNA segments are expressed to yield exogenous polypeptides.
  • a "homologous" nucleic acid (e.g. DNA) sequence is a nucleic acid (e.g. DNA) sequence naturally associated with a host cell into which it is introduced.
  • Hybridization refers to the binding, duplexing, or hybridizing of a molecule only to a particular nucleotide sequence under stringent conditions when that sequence is present in a complex mixture (e.g., total cellular) DNA or RNA.
  • Bod(s) substantially refers to complementary hybridization between a probe nucleic acid and a target nucleic acid and embraces minor mismatches that can be accommodated by reducing the stringency of the hybridization media to achieve the desired detection of the target nucleic acid sequence.
  • Inhibitor a chemical substance that inactivates the enzymatic activity of a protein such as a biosynthetic enzyme, receptor, signal transduction protein, structural gene product, or transport protein.
  • herbicide (or “herbicidal compound”) is used herein to define an inhibitor applied to a plant at any stage of development, whereby the herbicide inhibits the growth of the plant or kills the plant.
  • a nucleic acid sequence is "isocoding with" a reference nucleic acid sequence when the nucleic acid sequence encodes a polypeptide having the same amino acid sequence as the polypeptide encoded by the reference nucleic acid sequence.
  • Isogenic plants that are genetically identical, except that they may differ by the presence or absence of a heterologous DNA sequence.
  • an isolated DNA molecule or an isolated enzyme in the context of the present invention, is a DNA molecule or enzyme that, by human intervention, exists apart from its native environment and is therefore not a product of nature.
  • An isolated DNA molecule or enzyme may exist in a purified form or may exist in a non-native environment such as, for example, in a transgenic host cell.
  • Mature protein protein from which the transit peptide, signal peptide, and/or propeptide portions have been removed.
  • Minimal Promoter the smallest piece of a promoter, such as a TATA element, that can support any transcription.
  • a minimal promoter typically has greatly reduced promoter activity in the absence of upstream activation. In the presence of a suitable transcription factor, the minimal promoter functions to permit transcription.
  • Modified Enzyme Activity enzyme activity different from that which naturally occurs in a plant (i.e. enzyme activity that occurs naturally in the absence of direct or indirect manipulation of such activity by man), which is tolerant to inhibitors that inhibit the naturally occurring enzyme activity.
  • Native refers to a gene that is present in the genome of an untransformed plant cell.
  • Naturally occurring is used to describe an object that can be found in nature as distinct from being artificially produced by man.
  • a protein or nucleotide sequence present in an organism which can be isolated from a source in nature and which has not been intentionally modified by man in the laboratory, is naturally occurring.
  • nucleic acid refers to deoxyribonucleotides or ribonucleotides and polymers thereof in either single- or double-stranded form. Unless specifically limited, the term encompasses nucleic acids containing known analogues of natural nucleotides which have similar binding properties as the reference nucleic acid and are metabolized in a manner similar to naturally occurring nucleotides. Unless otherwise indicated, a particular nucleic acid sequence also implicitly encompasses conservatively modified variants thereof (e.g. degenerate codon substitutions) and complementary sequences and as well as the sequence explicitly indicated.
  • degenerate codon substitutions may be achieved by generating sequences in which the third position of one or more selected (or all) codons is substituted with mixed-base and/or deoxyinosine residues (Batzer et al., Nucleic Acid Res. 19: 5081 (1991); Ohtsuka et al., J. Biol. Chem. 260: 2605-2608 (1985); Rossolini et al., MoI. Cell. Probes 8: 91-98 (1994)).
  • the terms "nucleic acid” or “nucleic acid sequence” may also be used interchangeably with gene, cDNA, and mRNA encoded by a gene. "ORF” means open reading frame.
  • Percent identity refers to two or more sequences or subsequences that have for example 60%, specifically 70%, more specifically 80%, still more specifically 90%, even more specifically 95%, and most specifically at least 99% nucleotide or amino acid residue identity, when compared and aligned for maximum correspondence, as measured using one of the following sequence comparison algorithms or by visual inspection.
  • the percent identity exists over a region of the sequences that is at least about 50 residues in length, more specifically over a region of at least about 100 residues, and most specifically the percent identity exists over at least about 150 residues. In an especially specific embodiment, the percent identity exists over the entire length of the coding regions.
  • sequence comparison typically one sequence acts as a reference sequence to which test sequences are compared.
  • test and reference sequences are input into a computer, subsequence coordinates are designated if necessary, and sequence algorithm program parameters are designated.
  • sequence comparison algorithm then calculates the percent sequence identity for the test sequence(s) relative to the reference sequence, based on the designated program parameters.
  • Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2: 482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. MoI. Biol. 48: 443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Nat'l.
  • HSPs high scoring sequence pairs
  • initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them.
  • the word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always > 0) and N (penalty score for mismatching residues; always ⁇ 0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when the cumulative alignment score falls off by the quantity X from its maximum achieved value, the cumulative score goes to zero or below due to the accumulation of one or more negative-scoring residue alignments, or the end of either sequence is reached.
  • the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
  • the BLASTP program uses as defaults a wordlength (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89: 10915 (1989)).
  • the BLAST algorithm In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul, Proc. Nat'l. Acad. Sci. USA 90: 5873-5787 (1993)).
  • One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.
  • a test nucleic acid sequence is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid sequence to the reference nucleic acid sequence is less than about 0.1 , more specifically less than about 0.01 , and most specifically less than about 0.001.
  • Pre-protein protein that is normally targeted to a cellular organelle, such as a chloroplast, and still comprises its native transit peptide.
  • Purified the term "purified," when applied to a nucleic acid or protein, denotes that the nucleic acid or protein is essentially free of other cellular components with which it is associated in the natural state. It is specifically in a homogeneous state although it can be in either a dry or aqueous solution. Purity and homogeneity are typically determined using analytical chemistry techniques such as polyacrylamide gel electrophoresis or high performance liquid chromatography. A protein that is the predominant species present in a preparation is substantially purified.
  • nucleic acid or protein gives rise to essentially one band in an electrophoretic gel. Particularly, it means that the nucleic acid or protein is at least about 50% pure, more specifically at least about 85% pure, and most specifically at least about 99% pure.
  • Two nucleic acids are “recombined” when sequences from each of the two nucleic acids are combined in a progeny nucleic acid.
  • Two sequences are “directly” recombined when both of the nucleic acids are substrates for recombination.
  • Two sequences are "indirectly recombined” when the sequences are recombined using an intermediate such as a cross-over oligonucleotide.
  • no more than one of the sequences is an actual substrate for recombination, and in some cases, neither sequence is a substrate for recombination.
  • Regulatory elements refer to sequences involved in controlling the expression of a nucleotide sequence. Regulatory elements comprise a promoter operatively linked to the nucleotide sequence of interest and termination signals. They also typically encompass sequences required for proper translation of the nucleotide sequence.
  • the specified antibodies bind to a particular protein and do not bind in a significant amount to other proteins present in the sample. Specific binding to an antibody under such conditions may require an antibody that is selected for its specificity for a particular protein.
  • antibodies raised to the protein with the amino acid sequence encoded by any of the nucleic acid sequences of the invention can be selected to obtain antibodies specifically immunoreactive with that protein and not with other proteins except for polymorphic variants.
  • a variety of immunoassay formats may be used to select antibodies specifically immunoreactive with a particular protein.
  • solid-phase ELISA immunoassays, Western blots, or immunohistochemistry are routinely used to select monoclonal antibodies specifically immunoreactive with a protein. See Harlow and Lane (1988) Antibodies, A Laboratory Manual, Cold Spring Harbor Publications, New York "Harlow and Lane"), for a description of immunoassay formats and conditions that can be used to determine specific immunoreactivity.
  • a specific or selective reaction will be at least twice background signal or noise and more typically more than 10 to 100 times background.
  • “Stringent hybridization conditions” and “stringent hybridization wash conditions” in the context of nucleic acid hybridization experiments such as Southern and Northern hybridizations are sequence dependent, and are different under different environmental parameters. Longer sequences hybridize specifically at higher temperatures. An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology-Hybridization with Nucleic Acid Probes part I chapter 2 "Overview of principles of hybridization and the strategy of nucleic acid probe assays" Elsevier, New York.
  • highly stringent hybridization and wash conditions are selected to be about 5 0 C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH.
  • Tm thermal melting point
  • a probe will hybridize to its target subsequence, but to no other sequences.
  • the Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe.
  • Very stringent conditions are selected to be equal to the Tm for a particular probe.
  • An example of stringent hybridization conditions for hybridization of complementary nucleic acids which have more than 100 complementary residues on a filter in a Southern or northern blot is 50% formamide with 1 mg of heparin at 42 0 C, with the hybridization being carried out overnight.
  • An example of highly stringent wash conditions is 0.1 5M NaCI at 72 0 C for about 15 minutes.
  • An example of stringent wash conditions is a 0.2x SSC wash at 65 0 C for 15 minutes (see, Sambrook, infra, for a description of SSC buffer).
  • a high stringency wash is preceded by a low stringency wash to remove background probe signal.
  • An example medium stringency wash for a duplex of, e.g., more than 100 nucleotides, is 1x SSC at 45 0 C for 15 minutes.
  • An example low stringency wash for a duplex of, e.g., more than 100 nucleotides, is 4-6x SSC at 4O 0 C for 15 minutes.
  • stringent conditions typically involve salt concentrations of less than about 1.0 M Na ion, typically about 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3, and the temperature is typically at least about 3O 0 C.
  • Stringent conditions can also be achieved with the addition of destabilizing agents such as formamide.
  • destabilizing agents such as formamide.
  • a signal to noise ratio of 2x (or higher) than that observed for an unrelated probe in the particular hybridization assay indicates detection of a specific hybridization.
  • Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the proteins that they encode are substantially identical. This occurs, e.g., when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code.
  • a reference nucleotide sequence specifically hybridizes to the reference nucleotide sequence in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 5O 0 C with washing in 2X SSC, 0.1% SDS at 50 0 C, more desirably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50°C with washing in 1X SSC, 0.1 % SDS at 5O 0 C, more desirably still in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50°C with washing in 0.5X SSC, 0.1% SDS at 50 0 C, specifically in 7% sodium dodecyl
  • a “subsequence” refers to a sequence of nucleic acids or amino acids that comprise a part of a longer sequence of nucleic acids or amino acids (e.g., protein) respectively.
  • Substantial similarity in the context of two nucleic acid or protein sequences, refers to two or more sequences or subsequences that are substantially similar, for example that have 50%, specifically 60%, more specifically 70%, even more specifically 80%, still more specifically 90%, further more specifically 95%, and most specifically 99% sequence identity.
  • Substrate a substrate is the molecule that an enzyme naturally recognizes and converts to a product in the biochemical pathway in which the enzyme naturally carries out its function, or is a modified version of the molecule, which is also recognized by the enzyme and is converted by the enzyme to a product in an enzymatic reaction similar to the naturally-occurring reaction.
  • Transformation a process for introducing heterologous DNA into a plant cell, plant tissue, or plant.
  • Transformed plant cells, plant tissue, or plants are understood to encompass not only the end product of a transformation process, but also transgenic progeny thereof.
  • Transformed refers to a host organism such as a bacterium or a plant into which a heterologous nucleic acid molecule has been introduced.
  • the nucleic acid molecule can be stably integrated into the genome of the host or the nucleic acid molecule can also be present as an extrachromosomal molecule. Such an extrachromosomal molecule can be auto-replicating.
  • Transformed cells, tissues, or plants are understood to encompass not only the end product of a transformation process, but also transgenic progeny thereof.
  • non-transformed refers to a wild-type organism, e.g., a bacterium or plant, which does not contain the heterologous nucleic acid molecule.
  • Viability refers to a fitness parameter of a plant. Plants are assayed for their homozygous performance of plant development, indicating which proteins are essential for plant growth. DETAILED DESCRIPTION OF THE INVENTION I. General Description of Trait Functional Genomics
  • bioinformatics can assign function to a given gene by identifying genes in heterologous organisms with a high degree of similarity (homology) at the amino acid or nucleotide level.
  • expression of a gene at the mRNA or protein levels can assign function by linking expression of a gene to an environmental response, a developmental process or a genetic (mutational) or molecular genetic (gene overexpression or underexpression) perturbation.
  • Expression of a gene at the mRNA level can be ascertained either alone (Northern analysis) or in concert with other genes (microarray analysis), whereas expression of a gene at the protein level can be ascertained either alone (native or denatured protein gel or immunoblot analysis) or in concert with other genes (proteomic analysis).
  • Knowledge of protein/protein and protein/DNA interactions can assign function by identifying proteins and nucleic acid sequences acting together in the same biological process.
  • Genetics can assign function to a gene by demonstrating that DNA lesions (mutations) in the gene have a quantifiable effect on the organism, including but not limited to: its development; hormone biosynthesis and response; growth and growth habit (plant architecture); mRNA expression profiles; protein expression profiles; ability to resist diseases; tolerance of abiotic stresses; ability to acquire nutrients; photosynthetic efficiency; altered primary and secondary metabolism; and the composition of various plant organs.
  • Biochemistry can assign function by demonstrating that the protein encoded by the gene, typically when expressed in a heterologous organism, possesses a certain enzymatic activity, alone or in combination with other proteins.
  • Molecular genetics can assign function by overexpressing or underexpressing the gene in the native plant or in heterologous organisms, and observing quantifiable effects as described in functional assignment by genetics above.
  • functional genomics any or all of these approaches are utilized, often in concert, to assign genes to functions across any of a number of organismal phenotypes.
  • these different methodologies can each provide data as evidence for the function of a particular gene, and that such evidence is stronger with increasing amounts of data used for functional assignment: specifically from a single methodology, more specifically from two methodologies, and even more specifically from more than two methodologies.
  • those skilled in the art are aware that different methodologies can differ in the strength of the evidence for the assignment of gene function.
  • a datum of biochemical, genetic and molecular genetic evidence is considered stronger than a datum of bioinformatic or gene expression evidence.
  • crop trait functional genomics is to identify crop trait genes, i.e. genes capable of conferring useful agronomic traits in crop plants.
  • agronomic traits include, but are not limited to: enhanced yield, whether in quantity or quality; enhanced nutrient acquisition and enhanced metabolic efficiency; enhanced or altered nutrient composition of plant tissues used for food, feed, fiber or processing; enhanced utility for agricultural or industrial processing; enhanced resistance to plant diseases; enhanced tolerance of adverse environmental conditions (abiotic stresses) including but not limited to drought, excessive cold, excessive heat, or excessive soil salinity or extreme acidity or alkalinity; and alterations in plant architecture or development, including changes in developmental timing.
  • the deployment of such identified trait genes by either transgenic or non-transgenic means could materially improve crop plants for the benefit of agriculture.
  • Cereals are the most important crop plants on the planet, in terms of both human and animal consumption. Genomic synteny (conservation of gene order within large chromosomal segments) is observed in rice, maize, wheat, barley, rye, oats and other agriculturally important monocots, which facilitates the mapping and isolation of orthologous genes from diverse cereal species based on the sequence of a single cereal gene. Rice has the smallest ( ⁇ 420 Mb) genome among the cereal grains, and has recently been a major focus of public and private genomic and EST sequencing efforts.
  • genes from the rice draft genome sequence [wheat EST databases] were prioritized based on one or more functional genomic methodologies. For example, genome-wide expression studies of rice plants infected with rice blast fungus (Magnaporthe grisea) were used to prioritize candidate genes controlling disease resistance. Full-length and partial cDNAs of rice trait gene candidates could then be predicted based on analysis of the rice whole- genome sequence, and isolated by designing and using primers for PCR amplification using a commercially available PCR primer-picking program. Primers were used for PCR amplification of full-length or partial cDNAs from rice cDNA libraries or first-strand cDNA.
  • cDNA clones resulting from either approach were used for the construction of vectors designed for altering expression of these genes in transgenic plants using plant molecular genetic methodologies, which are described in detail below.
  • Alteration of plant phenotype through overexpression or underexpression of key trait genes in transgenic plants is a robust and established method for assigning functions to plant genes.
  • Assays to identify transgenic plants with alterations in traits of interest are to be used to unambiguously assign the utility of these genes for the improvement of rice, and by extension, other cereals, either by transgenic or classical breeding methods.
  • Example 1 The cloning and sequencing of the cDNAs of the present invention are described in Example 1.
  • the isolated nucleic acids and proteins of the present invention are usable over a range of plants, monocots and dicots, in particular monocots such as rice, wheat, barley and maize.
  • the monocot is a cereal.
  • the cereal may be, for example, maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, milo, flax, gramma grass, Tripsacum sp., or teosinte.
  • the cereal is rice.
  • plants genera include, but are not limited to, Cucurbita, Rosa, Vitis, Juglans, Gragaria, Lotus, Medicago, Onobrychis, Trigonella, Vigna, Citrus, Linum, Geranium, Manihot, Daucus, Arabidopsis, Brassica, Raphanus, Sinapis, Atropa, Capsicum, Datura, Hyoscyamus, Lycopersicon, Nicotiana, Solanum, Petunia, Digitalis, Majorana, Ciahorium, Helianthus, Lactuca, Bromus, Asparagus, Antirrhinum, Heterocallis, Nemesis, Pelargonium, Panieum, Pennisetum, Ranunculus, Senecio, Salpiglossis, Cucumis, Browaalia, Glycine, Pisum, Phaseolus, Lolium, Oryza, Avena, Hordeum, Secale, Allium, and Triticum.
  • the present invention also provides a method of genotyping a plant or plant part comprising a nucleic acid molecule of the present invention.
  • the plant is a monocot such as, but not limited rice or wheat.
  • Genotyping provides a means of distinguishing homologs of a chromosome pari and can be used to differentiate segregants in a plant population.
  • the method of genotyping may employ any number of molecular marker analytical techniques such as, but not limited to, restriction length polymorphisms (RFLPs).
  • RFLPs are produced by differences in the DNA restriction fragment lengths resulting from nucleotide differences between alleles of the same gene.
  • the present invention provides a method of following segregation of a gene or nucleic acid of the present invention or chromosomal sequences genetically linked by using RFLP analysis.
  • Linked chromosomal sequences are within 50 centiMorgans (50 cM), within 40 or 30 cM, specifically within 20 or 10 cM, more specifically within 5, 3, 2, or 1 cM of the nucleic acid of the invention.
  • the present invention encompasses the identification and isolation of polynucleotides encoding proteins involved in sugar sensing and, ultimately, in nitrogen uptake and carbon metabolism. Altering the expression of genes related to these traits can be used to improve or modify plants and/or grain, as desired. Examples describe the isolated genes of interest and methods of analyzing the alteration of expression and their effects on the plant characteristics.
  • compositions and methods for modulating or altering i.e. increasing or decreasing
  • the nucleic acid molecules and polypeptides of the invention are expressed constitutively, temporally or spatially, e.g. at developmental stages, in certain tissues, and/or quantities, which are uncharacteristic of non- recombinantly engineered plants. Therefore, the present invention provides utility in such exemplary applications as altering the specified characteristics identified above. Vl. Controlling Gene Expression in Transgenic Plants
  • the invention further relates to transformed cells comprising the nucleic acid molecules, transformed plants, seeds, and plant parts, and methods of modifying phenotypic traits of interest by altering the expression of the genes of the invention.
  • the transgenic expression in plants of genes derived from heterologous sources may involve the modification of those genes to achieve and optimize their expression in plants.
  • bacterial ORFs which encode separate enzymes but which are encoded by the same transcript in the native microbe are best expressed in plants on separate transcripts.
  • each microbial ORF is isolated individually and cloned within a cassette which provides a plant promoter sequence at the 5' end of the ORF and a plant transcriptional terminator at the 3' end of the ORF.
  • the isolated ORF sequence specifically includes the initiating ATG codon and the terminating STOP codon but may include additional sequence beyond the initiating ATG and the STOP codon.
  • the ORF may be truncated, but still retain the required activity; for particularly long ORFs, truncated versions which retain activity may be preferable for expression in transgenic organisms.
  • plant promoter and "plant transcriptional terminator” it is intended to mean promoters and transcriptional terminators that operate within plant cells. This includes promoters and transcription terminators that may be derived from non-plant sources such as viruses (an example is the Cauliflower Mosaic Virus).
  • modification to the ORF coding sequences and adjacent sequence is not required. It is sufficient to isolate a fragment containing the ORF of interest and to insert it downstream of a plant promoter.
  • Gaffney et al. (Science 261 : 754-756 (1993)) have expressed the Pseudomonas nahG gene in transgenic plants under the control of the CaMV 35S promoter and the CaMV tml terminator successfully without modification of the coding sequence and with nucleotides of the Pseudomonas gene upstream of the ATG still attached, and nucleotides downstream of the STOP codon still attached to the nahG ORF.
  • as little adjacent microbial sequence as possible should be left attached upstream of the ATG and downstream of the STOP codon. In practice, such construction may depend on the availability of restriction sites.
  • genes derived from microbial sources may provide problems in expression. These problems have been well characterized in the art and are particularly common with genes derived from certain sources such as Bacillus. These problems may apply to the nucleotide sequence of this invention and the modification of these genes can be undertaken using techniques now well known in the art. The following problems may be encountered: 1. Codon Usage. The specific codon usage in plants differs from the specific codon usage in certain microorganisms. Comparison of the usage of codons within a cloned microbial ORF to usage in plant genes (and in particular genes from the target plant) will enable an identification of the codons within the ORF that should specifically be changed.
  • Plant genes typically have a GC content of more than 35%.
  • ORF sequences which are rich in A and T nucleotides can cause several problems in plants. Firstly, motifs of ATTTA are believed to cause destabilization of messages and are found at the 3' end of many short-lived mRNAs. Secondly, the occurrence of polyadenylation signals such as AATAAA at inappropriate positions within the message is believed to cause premature truncation of transcription. In addition, monocotyledons may recognize AT-rich sequences as splice sites (see below).
  • Plants differ from microorganisms in that their messages do not possess a defined ribosome-binding site. Rather, it is believed that ribosomes attach to the 5' end of the message and scan for the first available ATG at which to start translation. Nevertheless, it is believed that there is a preference for certain nucleotides adjacent to the ATG and that expression of microbial genes can be enhanced by the inclusion of a eukaryotic consensus translation initiator at the ATG.
  • Clontech (1993/1994 catalog, page 210, incorporated herein by reference) have suggested one sequence as a consensus translation initiator for the expression of the E. coli uidA gene in plants. Further, Joshi (N.A.R.
  • Genes cloned from non-plant sources and not optimized for expression in plants may also contain motifs which may be recognized in plants as 5' or 3' splice sites, and be cleaved, thus generating truncated or deleted messages. These sites can be removed using the techniques well known in the art.
  • Coding sequences intended for expression in transgenic plants are first assembled in expression cassettes behind a suitable promoter expressible in plants.
  • the expression cassettes may also comprise any further sequences required or selected for the expression of the transgene.
  • Such sequences include, but are not restricted to, transcription terminators, extraneous sequences to enhance expression such as introns, vital sequences, and sequences intended for the targeting of the gene product to specific organelles and cell compartments.
  • the selection of the promoter used in expression cassettes will determine the spatial and temporal expression pattern of the transgene in the transgenic plant. Selected promoters will express transgenes in specific cell types (such as leaf epidermal cells, mesophyll cells, root cortex cells) or in specific tissues or organs (roots, leaves or flowers, for example) and the selection will reflect the desired location of accumulation of the gene product. Alternatively, the selected promoter may drive expression of the gene under various inducing conditions. Promoters vary in their strength, i.e., ability to promote transcription. Depending upon the host cell system utilized, any one of a number of suitable promoters can be used, including the gene's native promoter. The following are non-limiting examples of promoters that may be used in expression cassettes.
  • Ubiquitin is a gene product known to accumulate in many cell types and its promoter has been cloned from several species for use in transgenic plants (e.g. sunflower - Binet et al. Plant Science 79: 87-94 (1991); maize - Christensen et al. Plant Molec. Biol. 12: 619-632 (1989); and Arabidopsis - Callis et al., J. Biol. Chem. 265:12486-12493 (1990) and Norris et al., Plant MoI. Biol. 21 :895-906 (1993)).
  • the maize ubiquitin promoter has been developed in transgenic monocot systems and its sequence and vectors constructed for monocot transformation are disclosed in the patent publication EP 0 342 926 (to Lubrizol) which is herein incorporated by reference.
  • Taylor et al. Plant Cell Rep. 12: 491-495 (1993) describe a vector (pAHC25) that comprises the maize ubiquitin promoter and first intron and its high activity in cell suspensions of numerous monocotyledons when introduced via microprojectile bombardment.
  • the Arabidopsis ubiquitin promoter is ideal for use with the nucleotide sequences of the present invention.
  • the ubiquitin promoter is suitable for gene expression in transgenic plants, both monocotyledons and dicotyledons.
  • Suitable vectors are derivatives of pAHC25 or any of the transformation vectors described in this application, modified by the introduction of the appropriate ubiquitin promoter and/or intron sequences.
  • b. Constitutive Expression, the CaMV 35S Promoter Construction of the plasmid pCGN1761 is described in the published patent application EP 0 392 225 (Example 23), which is hereby incorporated by reference.
  • pCGN1761 contains the "double" CaMV 35S promoter and the tml transcriptional terminator with a unique EcoRI site between the promoter and the terminator and has a pUC-type backbone.
  • a derivative of pCGN1761 is constructed which has a modified polylinker which includes Notl and Xhol sites in addition to the existing EcoRI site. This derivative is designated pCGN1761 ENX.
  • pCGN1761 ENX is useful for the cloning of cDNA sequences or coding sequences (including microbial ORF sequences) within its polylinker for the purpose of their expression under the control of the 35S promoter in transgenic plants.
  • the entire 35S promoter-coding sequence-tml terminator cassette of such a construction can be excised by Hindlll, Sphl, Sail, and Xbal sites 5' to the promoter and Xbal, BamHI and BgII sites 3' to the terminator for transfer to transformation vectors such as those described below.
  • the double 35S promoter fragment can be removed by 5' excision with Hindlll, Sphl, Sail, Xbal, or Pstl, and 3' excision with any of the polylinker restriction sites (EcoRI, Notl or Xhol) for replacement with another promoter.
  • modifications around the cloning sites can be made by the introduction of sequences that may enhance translation. This is particularly useful when overexpression is desired.
  • pCGN1761 ENX may be modified by optimization of the translational initiation site as described in Example 37 of U.S. Patent No. 5,639,949, incorporated herein by reference.
  • c. Constitutive Expression, the Actin Promoter Several isoforms of actin are known to be expressed in most cell types and consequently the actin promoter is a good choice for a constitutive promoter.
  • the promoter from the rice Actl gene has been cloned and characterized (McElroy et al. Plant Cell 2: 163-171 (1990)). A 1.3kb fragment of the promoter was found to contain all the regulatory elements required for expression in rice protoplasts.
  • promoter- containing fragments is removed from the McElroy constructions and used to replace the double 35S promoter in pCGN1761 ENX, which is then available for the insertion of specific gene sequences.
  • the fusion genes thus constructed can then be transferred to appropriate transformation vectors.
  • the rice Actl promoter with its first intron has also been found to direct high expression in cultured barley cells (Chibbar et al. Plant Cell Rep. 12: 506-509 (1993)).
  • the double 35S promoter in pCGN 1761 ENX may be replaced with any other promoter of choice that will result in suitably high expression levels.
  • one of the chemically regulatable promoters described in U.S. Patent No. 5,614,395, such as the tobacco PR-Ia promoter may replace the double 35S promoter.
  • the Arabidopsis PR-1 promoter described in Lebel et al., Plant J. 16:223-233 (1998) may be used.
  • the promoter of choice is specifically excised from its source by restriction enzymes, but can alternatively be PCR-amplified using primers that carry appropriate terminal restriction sites.
  • the chemically/pathogen regulatable tobacco PR-Ia promoter is cleaved from plasmid pCIB1004 (for construction, see example 21 of EP 0 332 104, which is hereby incorporated by reference) and transferred to plasmid PCGN1761 ENX (Uknes et al., Plant Cell 4: 645-656 (1992)).
  • pCIB1004 is cleaved with Ncol and the resultant 3 1 overhang of the linearized fragment is rendered blunt by treatment with T4 DNA polymerase.
  • the fragment is then cleaved with Hindlll and the resultant PR-Ia promoter-containing fragment is gel purified and cloned into pCGN1761ENX from which the double 35S promoter has been removed. This is accomplished by cleavage with Xhol and blunting with T4 polymerase, followed by cleavage with Hindlll, and isolation of the larger vector-terminator containing fragment into which the pCIB1004 promoter fragment is cloned. This generates a pCGN1761 ENX derivative with the PR-Ia promoter and the tml terminator and an intervening polylinker with unique EcoRI and Notl sites. The selected coding sequence can be inserted into this vector, and the fusion products (i.e.
  • promoter-gene- terminator can subsequently be transferred to any selected transformation vector, including those described infra.
  • Various chemical regulators may be employed to induce expression of the selected coding sequence in the plants transformed according to the present invention, including the benzothiadiazole, isonicotinic acid, and salicylic acid compounds disclosed in U.S. Patent Nos. 5,523,311 and 5,614,395.
  • e. Inducible Expression, an Ethanol-lnducible Promoter A promoter inducible by certain alcohols or ketones, such as ethanol, may also be used to confer inducible expression of a coding sequence of the present invention.
  • Such a promoter is for example the alcA gene promoter from Aspergillus nidulans (Caddick et al. (1998) Nat. Biotechnol 16:177-180).
  • the alcA gene encodes alcohol dehydrogenase I, the expression of which is regulated by the AIcR transcription factors in presence of the chemical inducer.
  • the CAT coding sequences in plasmid palcA:CAT comprising a alcA gene promoter sequence fused to a minimal 35S promoter (Caddick et al. (1998) Nat.
  • Biotechnol 16:177-180 are replaced by a coding sequence of the present invention to form an expression cassette having the coding sequence under the control of the alcA gene promoter. This is carried out using methods well known in the art.
  • a Glucocorticoid-Inducible Promoter Induction of expression of a nucleic acid sequence of the present invention using systems based on steroid hormones is also contemplated.
  • a glucocorticoid-mediated induction system is used (Aoyama and Chua (1997) The Plant Journal 11 : 605-612) and gene expression is induced by application of a glucocorticoid, for example a synthetic glucocorticoid, specifically dexamethasone, specifically at a concentration ranging from 0.1mM to 1mM, more specifically from 1OmM to 10OmM.
  • a glucocorticoid for example a synthetic glucocorticoid, specifically dexamethasone, specifically at a concentration ranging from 0.1mM to 1mM, more specifically from 1OmM to 10OmM.
  • the luciferase gene sequences are replaced by a nucleic acid sequence of the invention to form an expression cassette having a nucleic acid sequence of the invention under the control of six copies of the GAL4 upstream activating sequences fused to the 35S minimal promoter.
  • the trans-acting factor comprises the GAL4 DNA-binding domain (Keegan et al. (1986) Science 231 : 699-704) fused to the transactivating domain of the herpes viral protein VP16 (Triezenberg et al. (1988) Genes Devel. 2: 718-729) fused to the hormone-binding domain of the rat glucocorticoid receptor (Picard et al. (1988) Cell 54: 1073-1080).
  • the expression of the fusion protein is controlled either by a promoter known in the art or described here.
  • This expression cassette is also comprised in the plant comprising a nucleic acid sequence of the invention fused to the 6xGAL4/minimal promoter.
  • tissue- or organ-specificity of the fusion protein is achieved leading to inducible tissue- or organ-specificity of the insecticidal toxin.
  • Root Specific Expression Another pattern of gene expression is root expression.
  • a suitable root promoter is the promoter of the maize metallothionein-like (MTL) gene described by de Framond (FEBS 290: 103-106 (1991)) and also in U.S. Patent No. 5,466,785, incorporated herein by reference.
  • Wound-inducible promoters may also be suitable for gene expression. Numerous such promoters have been described (e.g. Xu et al. Plant Molec. Biol. 22: 573-588 (1993), Logemann et al. Plant Cell 1 : 151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22: 783-792 (1993), Firek et al. Plant Molec. Biol.
  • the gene sequence and promoter extending up to -1726 bp from the start of transcription are presented.
  • this promoter, or parts thereof can be transferred to a vector such as pCGN1761 where it can replace the 35S promoter and be used to drive the expression of a foreign gene in a pith- specific manner.
  • fragments containing the pith-specific promoter or parts thereof can be transferred to any vector and modified for utility in transgenic plants.
  • PPC phosphoenol carboxylase
  • WO 93/07278 describes the isolation of the maize calcium-dependent protein kinase (CDPK) gene which is expressed in pollen cells.
  • CDPK calcium-dependent protein kinase
  • the gene sequence and promoter extend up to 1400 bp from the start of transcription.
  • this promoter or parts thereof can be transferred to a vector such as pCGN1761 where it can replace the 35S promoter and be used to drive the expression of a nucleic acid sequence of the invention in a pollen-specific manner.
  • transcriptional terminators are available for use in expression cassettes. These are responsible for the termination of transcription beyond the transgene and correct mRNA polyadenylation. Appropriate transcriptional terminators are those that are known to function in plants and include the CaMV 35S terminator, the tml terminator, the nopaline synthase terminator and the pea rbcS E9 terminator. These can be used in both monocotyledons and dicotyledons. In addition, a gene's native transcription terminator may be used.
  • leader sequences derived from viruses are also known to enhance expression, and these are particularly effective in dicotyledonous cells.
  • TMV Tobacco Mosaic Virus
  • MCMV Maize Chlorotic Mottle Virus
  • AMV Alfalfa Mosaic Virus
  • leader sequences known in the art include but are not limited to: picornavirus leaders, for example, EMCV leader (Encephalomyocarditis 5' noncoding region) (Elroy-Stein, O., Fuerst, T. R., and Moss, B. PNAS USA 86:6126-6130 (1989)); potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allison et al., 1986); MDMV leader (Maize Dwarf Mosaic Virus); Virology 154:9-20); human immunoglobulin heavy-chain binding protein (BiP) leader, (Macejak, D.
  • EMCV leader Nephalomyocarditis 5' noncoding region
  • potyvirus leaders for example, TEV leader (Tobacco Etch Virus) (Allison et al., 1986); MDMV leader (Maize Dwarf Mosaic Virus); Virology 154:9-20
  • BiP human immunoglobulin heavy-chain binding protein
  • a minimal promoter By minimal promoter it is intended that the basal promoter elements are inactive or nearly so without upstream activation. Such a promoter has low background activity in plants when there is no transactivator present or when enhancer or response element binding sites are absent.
  • One minimal promoter that is particularly useful for target genes in plants is the Bz1 minimal promoter, which is obtained from the bronzel gene of maize.
  • the Bz1 core promoter is obtained from the "myc" mutant Bz1-luciferase construct pBz1 LucR98 via cleavage at the Nhel site located at -53 to -58. Roth et al., Plant Cell 3: 317 (1991).
  • the derived Bz1 core promoter fragment thus extends from -53 to +227 and includes the Bz1 intron-1 in the 5 1 untranslated region.
  • Also useful for the invention is a minimal promoter created by use of a synthetic TATA element.
  • the TATA element allows recognition of the promoter by RNA polymerase factors and confers a basal level of gene expression in the absence of activation (see generally, Mukumoto (1993) Plant MoI Biol 23: 995-1003; Green (2000) Trends Biochem Sci 25: 59-63) 4.
  • Targeting of the Gene Product Within the Cell Various mechanisms for targeting gene products are known to exist in plants and the sequences controlling the functioning of these mechanisms have been characterized in some detail. For example, the targeting of gene products to the chloroplast is controlled by a signal sequence found at the amino terminal end of various proteins which is cleaved during chloroplast import to yield the mature protein (e.g. Comai et al. J. Biol. Chem. 263: 15104-15109 (1988)).
  • DNA encoding for appropriate signal sequences can be isolated from the 5' end of the cDNAs encoding the RUBISCO protein, the CAB protein, the EPSP synthase enzyme, the GS2 protein and many other proteins which are known to be chloroplast localized. See also, the section entitled "Expression With Chloroplast Targeting" in Example 37 of U.S. Patent No. 5,639,949.
  • Other gene products are localized to other organelles such as the mitochondrion and the peroxisome (e.g. Unger et al. Plant Molec.
  • the cDNAs encoding these products can also be manipulated to effect the targeting of heterologous gene products to these organelles. Examples of such sequences are the nuclear-encoded ATPases and specific aspartate amino transferase isoforms for mitochondria. Targeting cellular protein bodies has been described by Rogers et al. (Proc. Natl. Acad. Sci. USA 82: 6512-6516 (1985)).
  • sequences have been characterized which cause the targeting of gene products to other cell compartments.
  • Amino terminal sequences are responsible for targeting to the ER, the apoplast, and extracellular secretion from aleurone cells (Koehler & Ho, Plant Cell 2: 769- 783 (1990)). Additionally, amino terminal sequences in conjunction with carboxy terminal sequences are responsible for vacuolar targeting of gene products (Shinshi et al. Plant Molec. Biol. 14: 357-368 (1990)).
  • the transgene product By the fusion of the appropriate targeting sequences described above to transgene sequences of interest it is possible to direct the transgene product to any organelle or cell compartment.
  • chloroplast targeting for example, the chloroplast signal sequence from the RUBISCO gene, the CAB gene, the EPSP synthase gene, or the GS2 gene is fused in frame to the amino terminal ATG of the transgene.
  • the signal sequence selected should include the known cleavage site, and the fusion constructed should take into account any amino acids after the cleavage site which are required for cleavage. In some cases this requirement may be fulfilled by the addition of a small number of amino acids between the cleavage site and the transgene ATG or, alternatively, replacement of some amino acids within the transgene sequence.
  • Fusions constructed for chloroplast import can be tested for efficacy of chloroplast uptake by in vitro translation of in vitro transcribed constructions followed by in vitro chloroplast uptake using techniques described by Bartlett et al. In: Edelmann et al. (Eds.) Methods in Chloroplast Molecular Biology, Elsevier pp 1081-1091 (1982) and Wasmann et al. MoI. Gen. Genet. 205: 446-453 (1986). These construction techniques are well known in the art and are equally applicable to mitochondria and peroxisomes.
  • transformation vectors available for plant transformation are known to those of ordinary skill in the plant transformation arts, and the genes pertinent to this invention can be used in conjunction with any such vectors.
  • the selection of vector will depend upon the specific transformation technique and the target species for transformation. For certain target species, different antibiotic or herbicide selection markers may be specific. Selection markers used routinely in transformation include the nptll gene, which confers resistance to kanamycin and related antibiotics (Messing & Vierra. Gene 19: 259-268 (1982); Bevan et al., Nature 304:184-187 (1983)), the bar gene, which confers resistance to the herbicide phosphinothricin (White et al., Nucl. Acids Res 18: 1062 (1990), Spencer et al.
  • vectors Suitable for Agrobacterium Transformation Many vectors are available for transformation using Agrobacterium tumefaciens. These typically carry at least one T-DNA border sequence and include vectors such as pBIN19 (Bevan, Nucl. Acids Res. (1984)). Below, the construction of two typical vectors suitable for Agrobacterium transformation is described. a. pCIB200 and pCIB2001 :
  • the binary vectors pCIB200 and pCIB2001 are used for the construction of recombinant vectors for use with Agrobacterium and are constructed in the following manner.
  • pTJS75kan is created by Narl digestion of pTJS75 (Schmidhauser & Helinski, J. Bacteriol.
  • Xhol linkers are ligated to the EcoRV fragment of PCIB7 which contains the left and right T-DNA borders, a plant selectable nos/nptll chimeric gene and the pUC polylinker (Rothstein et al., Gene 53: 153-161 (1987)), and the Xhol-digested fragment are cloned into Sail-digested pTJS75kan to create pCIB200 (see also EP 0 332 104, example 19).
  • pCIB200 contains the following unique polylinker restriction sites: EcoRI, Sstl, Kpnl, BgIII, Xbal, and Sail.
  • ⁇ CIB2001 is a derivative of pCIB200 created by the insertion into the polylinker of additional restriction sites.
  • Unique restriction sites in the polylinker of pCIB2001 are EcoRI, Sstl, Kpnl, BgIII, Xbal, Sail, MIuI, BcII, Avrll, Apal, Hpal, and Stul.
  • pCIB2001 in addition to containing these unique restriction sites also has plant and bacterial kanamycin selection, left and right T-DNA borders for Agrobacterium- mediated transformation, the RK2-derived trfA function for mobilization between E. coli and other hosts, and the OriT and OriV functions also from RK2.
  • the pCIB2001 polylinker is suitable for the cloning of plant expression cassettes containing their own regulatory signals.
  • the binary vector pCIBIO contains a gene encoding kanamycin resistance for selection in plants and T-DNA right and left border sequences and incorporates sequences from the wide host-range plasmid pRK252 allowing it to replicate in both E. coli and Agrobacterium. Its construction is described by Rothstein et al. (Gene 53: 153-161 (1987)). Various derivatives of pCIBIO are constructed which incorporate the gene for hygromycin B phosphotransferase described by Gritz et al. (Gene 25: 179-188 (1983)).
  • Vectors Suitable for non-Agrobacterium Transformation Transformation without the use of Agrobacterium tumefaciens circumvents the requirement for T-DNA sequences in the chosen transformation vector and consequently vectors lacking these sequences can be utilized in addition to vectors such as the ones described above which contain T-DNA sequences. Transformation techniques that do not rely on Agrobacterium include transformation via particle bombardment, protoplast uptake (e.g. PEG and electroporation) and microinjection. The choice of vector depends largely on the specific selection for the species being transformed.
  • pCIB3064 is a pUC-derived vector suitable for direct gene transfer techniques in combination with selection by the herbicide basta (or phosphinothricin).
  • the plasmid pCIB246 comprises the CaMV 35S promoter in operational fusion to the E. coli GUS gene and the CaMV 35S transcriptional terminator and is described in the PCT published application WO 93/07278.
  • the 35S promoter of this vector contains two ATG sequences 5' of the start site. These sites are mutated using standard PCR techniques in such a way as to remove the ATGs and generate the restriction sites Sspl and Pvull.
  • the new restriction sites are 96 and 37 bp away from the unique Sail site and 101 and 42 bp away from the actual start site.
  • the resultant derivative of pCIB246 is designated pCIB3025.
  • the GUS gene is then excised from pCIB3025 by digestion with Sail and Sacl, the termini rendered blunt and religated to generate plasmid pCIB3060.
  • the plasmid pJIT82 is obtained from the John lnnes Centre, Norwich and the a 400 bp Smal fragment containing the bar gene from Streptomyces viridochromogenes is excised and inserted into the Hpal site of pCIB3060 (Thompson et al.
  • pCIB3064 which comprises the bar gene under the control of the CaMV 35S promoter and terminator for herbicide selection, a gene for ampicillin resistance (for selection in E. coli) and a polylinker with the unique sites Sphl, Pstl, Hindlll, and BamHI.
  • This vector is suitable for the cloning of plant expression cassettes containing their own regulatory signals.
  • pSOG19 and pSOG35 pSOG35 is a transformation vector that utilizes the E. coli gene dihydrofolate reductase (DFR) as a selectable marker conferring resistance to methotrexate.
  • DFR dihydrofolate reductase
  • PCR is used to amplify the 35S promoter (-800 bp), intron 6 from the maize Adh1 gene (-550 bp) and 18 bp of the GUS untranslated leader sequence from pSOG10.
  • a 250-bp fragment encoding the E. coli dihydrofolate reductase type Il gene is also amplified by PCR and these two PCR fragments are assembled with a Sacl-Pstl fragment from pB1221 (Clontech) which comprises the pUC19 vector backbone and the nopaline synthase terminator.
  • pSOG19 which contains the 35S promoter in fusion with the intron 6 sequence, the GUS leader, the DHFR gene and the nopaline synthase terminator.
  • Replacement of the GUS leader in pSOG19 with the leader sequence from Maize Chlorotic Mottle Virus (MCMV) generates the vector pSOG35.
  • pSOG19 and pSOG35 carry the pUC gene for ampicillin resistance and have Hindlll, Sphl, Pstl and EcoRI sites available for the cloning of foreign substances. 3.
  • plastid transformation vector pPH143 (WO 97/32011 , example 36) is used.
  • the nucleotide sequence is inserted into pPH143 thereby replacing the PROTOX coding sequence.
  • This vector is then used for plastid transformation and selection of transformants for spectinomycin resistance.
  • the nucleotide sequence is inserted in pPH143 so that it replaces the aadH gene. In this case, transformants are selected for resistance to PROTOX inhibitors.
  • a nucleic acid sequence of the invention Once cloned into an expression system, it is transformed into a plant cell.
  • the receptor and target expression cassettes of the present invention can be introduced into the plant cell in a number of art-recognized ways. Methods for regeneration of plants are also well known in the art. For example, Ti plasmid vectors have been utilized for the delivery of foreign DNA, as well as direct DNA uptake, liposomes, electroporation, microinjection, and microprojectiles. In addition, bacteria from the genus Agrobacterium can be utilized to transform plant cells. Below are descriptions of representative techniques for transforming both dicotyledonous and monocotyledonous plants, as well as a representative plastid transformation technique. 1. Transformation of Dicotyledons
  • Transformation techniques for dicotyledons are well known in the art and include Agrobacterium-based techniques and techniques that do not require Agrobacterium.
  • Non-Agrobacterium techniques involve the uptake of exogenous genetic material directly by protoplasts or cells. This can be accomplished by PEG or electroporation mediated uptake, particle bombardment-mediated delivery, or microinjection. Examples of these techniques are described by Paszkowski et al., EMBO J 3: 2717-2722 (1984), Potrykus et al., MoI. Gen. Genet. 199: 169-177 (1985), Reich et al., Biotechnology 4: 1001-1004 (1986), and Klein et al., Nature 327: 70-73 (1987). In each case the transformed cells are regenerated to whole plants using standard techniques known in the art.
  • Agrobacterium-mediated transformation is a specific technique for transformation of dicotyledons because of its high efficiency of transformation and its broad utility with many different species.
  • Agrobacterium transformation typically involves the transfer of the binary vector carrying the foreign DNA of interest (e.g. ⁇ CIB200 or pCIB2001) to an appropriate Agrobacterium strain which may depend of the complement of vir genes carried by the host Agrobacterium strain either on a co-resident Ti plasmid or chromosomally (e.g. strain CIB542 for pCIB200 and pCIB2001 (Uknes et al. Plant Cell 5: 159-169 (1993)).
  • the transfer of the recombinant binary vector to Agrobacterium is accomplished by a triparental mating procedure using E. coli carrying the recombinant binary vector, a helper E. coli strain which carries a plasmid such as pRK2013 and which is able to mobilize the recombinant binary vector to the target Agrobacterium strain.
  • the recombinant binary vector can be transferred to Agrobacterium by DNA transformation (H ⁇ fgen & Willmitzer, Nucl. Acids Res. 16: 9877 (1988)). Transformation of the target plant species by recombinant
  • Agrobacterium usually involves co-cultivation of the Agrobacterium with explants from the plant and follows protocols well known in the art. Transformed tissue is regenerated on selectable medium carrying the antibiotic or herbicide resistance marker present between the binary plasmid T-DNA borders.
  • Another approach to transforming plant cells with a gene involves propelling inert or biologically active particles at plant tissues and cells.
  • This technique is disclosed in U.S. Patent Nos. 4,945,050, 5,036,006, and 5,100,792 all to Sanford et al.
  • this procedure involves propelling inert or biologically active particles at the cells under conditions effective to penetrate the outer surface of the cell and afford incorporation within the interior thereof.
  • the vector can be introduced into the cell by coating the particles with the vector containing the desired gene.
  • the target cell can be surrounded by the vector so that the vector is carried into the cell by the wake of the particle.
  • Biologically active particles e.g., dried yeast cells, dried bacterium or a bacteriophage, each containing DNA sought to be introduced
  • Transformation of Monocotyledons Transformation of most monocotyledon species has now also become routine. Specific techniques include direct gene transfer into protoplasts using PEG or electroporation techniques, and particle bombardment into callus tissue. Transformations can be undertaken with a single DNA species or multiple DNA species (i.e. co-transformation) and both these techniques are suitable for use with this invention. Co-transformation may have the advantage of avoiding complete vector construction and of generating transgenic plants with unlinked loci for the gene of interest and the selectable marker, enabling the removal of the selectable marker in subsequent generations, should this be regarded desirable. However, a disadvantage of the use of co-transformation is the less than 100% frequency with which separate DNA species are integrated into the genome (Schocher et al. Biotechnology 4: 1093-1096 (1986)).
  • Patent Applications EP 0 292 435, EP 0 392 225, and WO 93/07278 describe techniques for the preparation of callus and protoplasts from an elite inbred line of maize, transformation of protoplasts using PEG or electroporation, and the regeneration of maize plants from transformed protoplasts.
  • Gordon-Kamm et al. Plant Cell 2: 603-618 (1990)
  • Fromm et al. Biotechnology 8: 833-839 (1990)
  • WO 93/07278 and Koziel et al. describe techniques for the transformation of elite inbred lines of maize by particle bombardment. This technique utilizes immature maize embryos of 1.5-2.5 mm length excised from a maize ear 14-15 days after pollination and a PDS-1000He Biolistics device for bombardment.
  • Transformation of rice can also be undertaken by direct gene transfer techniques utilizing protoplasts or particle bombardment.
  • Protoplast-mediated transformation has been described for Japonica-types and Indica-types (Zhang et al. Plant Cell Rep 7: 379-384 (1988); Shimamoto et al. Nature 338: 274-277 (1989); Datta et al. Biotechnology 8: 736-740 (1990)). Both types are also routinely transformable using particle bombardment (Christou et al. Biotechnology 9: 957-962 (1991)).
  • WO 93/21335 describes techniques for the transformation of rice via electroporation.
  • Patent Application EP 0 332 581 describes techniques for the generation, transformation and regeneration of Pooideae protoplasts. These techniques allow the transformation of Dactylis and wheat. Furthermore, wheat transformation has been described by Vasil et al. (Biotechnology 10: 667-674 (1992)) using particle bombardment into cells of type C long-term regenerable callus, and also by Vasil et al. (Biotechnology 11 : 1553-1558 (1993)) and Weeks et al. (Plant Physiol. 102: 1077-1084 (1993)) using particle bombardment of immature embryos and immature embryo-derived callus.
  • a specific technique for wheat transformation involves the transformation of wheat by particle bombardment of immature embryos and includes either a high sucrose or a high maltose step prior to gene delivery.
  • any number of embryos (0.75-1 mm in length) are plated onto MS medium with 3% sucrose (Murashiga & Skoog, Physiologia Plantarum 15: 473-497 (1962)) and 3 mg/l 2,4-D for induction of somatic embryos, which is allowed to proceed in the dark.
  • MS medium with 3% sucrose
  • 3 mg/l 2,4-D for induction of somatic embryos, which is allowed to proceed in the dark.
  • embryos are removed from the induction medium and placed onto the osmoticum (i.e. induction medium with sucrose or maltose added at the desired concentration, typically 15%).
  • the embryos are allowed to plasmolyze for 2-3 hours and are then bombarded. Twenty embryos per target plate is typical, although not critical.
  • An appropriate gene-carrying plasmid (such as pCIB3064 or pSG35) is precipitated onto micrometer size gold particles using standard procedures.
  • Each plate of embryos is shot with the DuPont Biolistics® helium device using a burst pressure of -1000 psi using a standard 80 mesh screen. After bombardment, the embryos are placed back into the dark to recover for about 24 hours (still on osmoticum). After 24 hrs, the embryos are removed from the osmoticum and placed back onto induction medium where they stay for about a month before regeneration.
  • the embryo explants with developing embryogenic callus are transferred to regeneration medium (MS + 1 mg/liter NAA, 5 mg/liter GA), further containing the appropriate selection agent (10 mg/l basta in the case of pCIB3064 and 2 mg/l methotrexate in the case of pSOG35).
  • regeneration medium MS + 1 mg/liter NAA, 5 mg/liter GA
  • selection agent 10 mg/l basta in the case of pCIB3064 and 2 mg/l methotrexate in the case of pSOG35.
  • GA7s sterile containers which contain half- strength MS, 2% sucrose, and the same concentration of selection agent.
  • Embryogenic responses are initiated and/or cultures are established from mature embryos by culturing on MS-CIM medium (MS basal salts, 4.3 g/liter; B5 vitamins (200 x), 5 ml/liter; Sucrose, 30 g/liter; proline, 500 mg/liter; glutamine, 500 mg/liter; casein hydrolysate, 300 mg/liter; 2,4-D (1 mg/ml), 2 ml/liter; adjust pH to 5.8 with 1 N KOH; Phytagel, 3 g/liter).
  • Agrobacterium tumefaciens strain LBA4404 Agrobacterium containing the desired vector construction.
  • Agrobacterium is cultured from glycerol stocks on solid YPC medium (100 mg/L spectinomycin and any other appropriate antibiotic) for ⁇ 2 days at 28 oC.
  • Agrobacterium is re-suspended in liquid MS-CIM medium.
  • the Agrobacterium culture is diluted to an OD600 of 0.2-0.3 and acetosyringone is added to a final concentration of 200 uM.
  • Acetosyringone is added before mixing the solution with the rice cultures to induce Agrobacterium for DNA transfer to the plant cells.
  • the plant cultures are immersed in the bacterial suspension.
  • the liquid bacterial suspension is removed and the inoculated cultures are placed on co- cultivation medium and incubated at 22°C for two days.
  • the cultures are then transferred to MS-CIM medium with Ticarcillin (400 mg/liter) to inhibit the growth of Agrobacterium.
  • PMI selectable marker gene for constructs utilizing the PMI selectable marker gene (Reed et al., In Vitro Cell. Dev.
  • Biol.-Plant 37:127-132 cultures are transferred to selection medium containing Mannose as a carbohydrate source (MS with 2%Mannose, 300 mg/liter Ticarcillin) after 7 days, and cultured for 3-4 weeks in the dark. Resistant colonies are then transferred to regeneration induction medium (MS with no 2,4-D, 0.5 mg/liter IAA, 1 mg/liter zeatin, 200 mg/liter timentin 2% Mannose and 3% Sorbitol) and grown in the dark for 14 days. Proliferating colonies are then transferred to another round of regeneration induction media and moved to the light growth room.
  • MS Mannose as a carbohydrate source
  • regeneration induction medium MS with no 2,4-D, 0.5 mg/liter IAA, 1 mg/liter zeatin, 200 mg/liter timentin 2% Mannose and 3% Sorbitol
  • Regenerated shoots are transferred to GA7 containers with GA7-1 medium (MS with no hormones and 2% Sorbitol) for 2 weeks and then moved to the greenhouse when they are large enough and have adequate roots. Plants are transplanted to soil in the greenhouse (TO generation) grown to maturity, and the T1 seed is harvested. 3. Transformation of Plastids
  • Nicotiana tabacum c.v. 'Xanthi nc' are germinated seven per plate in a 1" circular array on T agar medium and bombarded 12-14 days after sowing with 1 ⁇ m tungsten particles (M10, Biorad, Hercules, CA) coated with DNA from plasmids pPH143 and pPH145 essentially as described (Svab, Z. and Maliga, P. (1993) PNAS 90, 913-917).
  • Bombarded seedlings are incubated on T medium for two days after which leaves are excised and placed abaxial side up in bright light (350-500 ⁇ mol photons/m2/s) on plates of RMOP medium (Svab, Z., Hajdukiewicz, P. and Maliga, P. (1990) PNAS 87, 8526-8530) containing 500 ⁇ g/ml spectinomycin dihydrochloride (Sigma, St. Louis, MO). Resistant shoots appearing underneath the bleached leaves three to eight weeks after bombardment are subcloned onto the same selective medium, allowed to form callus, and secondary shoots isolated and subcloned.
  • the plants obtained via tranformation with a nucleic acid sequence of the present invention can be any of a wide variety of plant species, including those of monocots and dicots; however, the plants used in the method of the invention are specifically selected from the list of agronomically important target crops set forth supra.
  • the expression of a gene of the present invention in combination with other characteristics important for production and quality can be incorporated into plant lines through breeding. Breeding approaches and techniques are known in the art. See, for example, Welsh J. R., Fundamentals of Plant Genetics and Breeding, John Wiley & Sons, NY (1981); Crop Breeding, Wood D. R.
  • the genetic properties engineered into the transgenic seeds and plants described above are passed on by sexual reproduction or vegetative growth and can thus be maintained and propagated in progeny plants.
  • said maintenance and propagation make use of known agricultural methods developed to fit specific purposes such as tilling, sowing or harvesting.
  • Specialized processes such as hydroponics or greenhouse technologies can also be applied.
  • measures are undertaken to control weeds, plant diseases, insects, nematodes, and other adverse conditions to improve yield.
  • transgenic plants and seeds according to the invention can further be made in plant breeding, which aims at the development of plants with improved properties such as tolerance of pests, herbicides, or stress, improved nutritional value, increased yield, or improved structure causing less loss from lodging or shattering.
  • the various breeding steps are characterized by well-defined human intervention such as selecting the lines to be crossed, directing pollination of the parental lines, or selecting appropriate progeny plants.
  • Hybridization techniques also include the sterilization of plants to yield male or female sterile plants by mechanical, chemical, or biochemical means. Cross pollination of a male sterile plant with pollen of a different line assures that the genome of the male sterile but female fertile plant will uniformly obtain properties of both parental lines.
  • the transgenic seeds and plants according to the invention can be used for the breeding of improved plant lines, that for example, increase the effectiveness of conventional methods such as herbicide or pesticide treatment or allow one to dispense with said methods due to their modified genetic properties.
  • new crops with improved stress tolerance can be obtained, which, due to their optimized genetic "equipment", yield harvested product of better quality than products that were not able to tolerate comparable adverse developmental conditions.
  • germination quality and uniformity of seeds are essential product characteristics. As it is difficult to keep a crop free from other crop and weed seeds, to control seedborne diseases, and to produce seed with good germination, fairly extensive and well-defined seed production practices have been developed by seed producers, who are experienced in the art of growing, conditioning and marketing of pure seed. Thus, it is common practice for the farmer to buy certified seed meeting specific quality standards instead of using seed harvested from his own crop.
  • Propagation material to be used as seeds is customarily treated with a protectant coating comprising herbicides, insecticides, fungicides, bactericides, nematicides, molluscicides, or mixtures thereof.
  • Customarily used protectant coatings comprise compounds such as captan, carboxin, thiram (TMTD®), methalaxyl (Apron®), and pirimiphos-methyl (Actellic®). If desired, these compounds are formulated together with further carriers, surfactants or application-promoting adjuvants customarily employed in the art of formulation to provide protection against damage caused by bacterial, fungal or animal pests.
  • the protectant coatings may be applied by impregnating propagation material with a liquid formulation or by coating with a combined wet or dry formulation. Other methods of application are also possible such as treatment directed at the buds or the fruit.
  • the alteration in expression of the nucleic acid molecules of the present invention is achieved in one of the following ways:
  • A. "Sense” Suppression Alteration of the expression of a nucleotide sequence of the present invention, specifically reduction of its expression, is obtained by “sense” suppression (referenced in e.g. Jorgensen et al. (1996) Plant MoI. Biol. 31 , 957-973).
  • the entirety or a portion of a nucleotide sequence of the present invention is comprised in a DNA molecule.
  • the DNA molecule is specifically operatively linked to a promoter functional in a cell comprising the target gene, specifically a plant cell, and introduced into the cell, in which the nucleotide sequence is expressible.
  • the nucleotide sequence is inserted in the DNA molecule in the "sense orientation", meaning that the coding strand of the nucleotide sequence can be transcribed.
  • the nucleotide sequence is fully translatable and all the genetic information comprised in the nucleotide sequence, or portion thereof, is translated into a polypeptide.
  • the nucleotide sequence is partially translatable and a short peptide is translated. In a specific embodiment, this is achieved by inserting at least one premature stop codon in the nucleotide sequence, which bring translation to a halt.
  • the nucleotide sequence is transcribed but no translation product is being made.
  • the DNA molecule comprising the nucleotide sequence, or a portion thereof is stably integrated in the genome of the plant cell.
  • the DNA molecule comprising the nucleotide sequence, or a portion thereof is comprised in an extrachromosomally replicating molecule.
  • the expression of the nucleotide sequence corresponding to the nucleotide sequence comprised in the DNA molecule is specifically reduced.
  • the nucleotide sequence in the DNA molecule is at least 70% identical to the nucleotide sequence the expression of which is reduced, more specifically it is at least 80% identical, yet more specifically at least 90% identical, yet more specifically at least 95% identical, yet more specifically at least 99% identical.
  • the alteration of the expression of a nucleotide sequence of the present invention is obtained by "anti-sense" suppression.
  • the entirety or a portion of a nucleotide sequence of the present invention is comprised in a DNA molecule.
  • the DNA molecule is specifically operatively linked to a promoter functional in a plant cell, and introduced in a plant cell, in which the nucleotide sequence is expressible.
  • the nucleotide sequence is inserted in the DNA molecule in the "anti-sense orientation", meaning that the reverse complement (also called sometimes non-coding strand) of the nucleotide sequence can be transcribed.
  • the DNA molecule comprising the nucleotide sequence, or a portion thereof is stably integrated in the genome of the plant cell.
  • the DNA molecule comprising the nucleotide sequence, or a portion thereof is comprised in an extrachromosomally replicating molecule.
  • the expression of the nucleotide sequence corresponding to the nucleotide sequence comprised in the DNA molecule is specifically reduced.
  • the nucleotide sequence in the DNA molecule is at least 70% identical to the nucleotide sequence the expression of which is reduced, more specifically it is at least 80% identical, yet more specifically at least 90% identical, yet more specifically at least 95% identical, yet more specifically at least 99% identical.
  • At least one genomic copy corresponding to a nucleotide sequence of the present invention is modified in the genome of the plant by homologous recombination as further illustrated in Paszkowski et al., EMBO Journal 7:4021-26 (1988).
  • This technique uses the property of homologous sequences to recognize each other and to exchange nucleotide sequences between each by a process known in the art as homologous recombination.
  • homologous recombination can occur between the chromosomal copy of a nucleotide sequence in a cell and an incoming copy of the nucleotide sequence introduced in the cell by transformation. Specific modifications are thus accurately introduced in the chromosomal copy of the nucleotide sequence.
  • the regulatory elements of the nucleotide sequence of the present invention are modified. Such regulatory elements are easily obtainable by screening a genomic library using the nucleotide sequence of the present invention, or a portion thereof, as a probe. The existing regulatory elements are replaced by different regulatory elements, thus altering expression of the nucleotide sequence, or they are mutated or deleted, thus abolishing the expression of the nucleotide sequence.
  • the nucleotide sequence is modified by deletion of a part of the nucleotide sequence or the entire nucleotide sequence, or by mutation. Expression of a mutated polypeptide in a plant cell is also contemplated in the present invention.
  • a mutation in the chromosomal copy of a nucleotide sequence is introduced by transforming a cell with a chimeric oligonucleotide composed of a contiguous stretch of RNA and DNA residues in a duplex conformation with double hairpin caps on the ends.
  • An additional feature of the oligonucleotide is for example the presence of 2'-O- methylation at the RNA residues.
  • RNA/DNA sequence is designed to align with the sequence of a chromosomal copy of a nucleotide sequence of the present invention and to contain the desired nucleotide change.
  • this technique is further illustrated in US patent 5,501 ,967 and Zhu et al. (1999) Proc. Natl. Acad. Sci. USA 96: 8768-8773.
  • D. Ribozymes are further illustrated in US patent 5,501 ,967 and Zhu et al. (1999) Proc. Natl. Acad. Sci. USA 96: 8768-8773.
  • the RNA coding for a polypeptide of the present invention is cleaved by a catalytic RNA, or ribozyme, specific for such RNA.
  • the ribozyme is expressed in transgenic plants and results in reduced amounts of RNA coding for the polypeptide of the present invention in plant cells, thus leading to reduced amounts of polypeptide accumulated in the cells. This method is further illustrated in US patent 4,987,071.
  • the activity of the polypeptide encoded by the nucleotide sequences of this invention is changed. This is achieved by expression of dominant negative mutants of the proteins in transgenic plants, leading to the loss of activity of the endogenous protein.
  • polypeptide of the present invention is inhibited by expressing in transgenic plants nucleic acid ligands, so-called aptamers, which specifically bind to the protein.
  • Aptamers are preferentially obtained by the SELEX (Systematic Evolution of Ligands by
  • Exponential Enrichment a candidate mixture of single stranded nucleic acids having regions of randomized sequence is contacted with the protein and those nucleic acids having an increased affinity to the target are partitioned from the remainder of the candidate mixture.
  • the partitioned nucleic acids are amplified to yield a ligand enriched mixture.
  • a nucleic acid with optimal affinity to the polypeptide is obtained and is used for expression in transgenic plants. This method is further illustrated in US patent 5,270,163.
  • Zinc finger proteins A zinc finger protein that binds a nucleotide sequence of the present invention or to its regulatory region is also used to alter expression of the nucleotide sequence.
  • Zinc finger proteins are for example described in Beerli et al. (1998) PNAS 95:14628-14633., or in WO 95/19431 , WO 98/54311 , or WO 96/06166, all incorporated herein by reference in their entirety.
  • Alteration of the expression of a nucleotide sequence of the present invention is also obtained by dsRNA interference as described for example in WO 99/32619, WO 99/53050 or WO 99/61631 , all incorporated herein by reference in their entirety.
  • the alteration of the expression of a nucleotide sequence of the present invention is obtained by double-stranded RNA (dsRNA) interference.
  • dsRNA double-stranded RNA
  • the entirety or, specifically a portion of a nucleotide sequence of the present invention is comprised in a DNA molecule.
  • the size of the DNA molecule is specifically from 100 to 1000 nucleotides or more; the optimal size to be determined empirically.
  • first and second copies are linked, separated by a spacer DNA molecule, such that the first and second copies are in opposite orientations.
  • the first copy of the DNA molecule is in the reverse complement (also known as the non-coding strand) and the second copy is the coding strand; in the most specific embodiment, the first copy is the coding strand, and the second copy is the reverse complement.
  • the size of the spacer DNA molecule is specifically 200 to 10,000 nucleotides, more specifically 400 to 5000 nucleotides and most specifically 600 to 1500 nucleotides in length.
  • the spacer is specifically a random piece of DNA, more specifically a random piece of DNA without homology to the target organism for dsRNA interference, and most specifically a functional intron which is effectively spliced by the target organism.
  • the two copies of the DNA molecule separated by the spacer are operatively linked to a promoter functional in a plant cell, and introduced in a plant cell, in which the nucleotide sequence is expressible.
  • the DNA molecule comprising the nucleotide sequence, or a portion thereof is stably integrated in the genome of the plant cell.
  • the DNA molecule comprising the nucleotide sequence, or a portion thereof is comprised in an extrachromosomally replicating molecule.
  • the expression of the nucleotide sequence corresponding to the nucleotide sequence comprised in the DNA molecule is specifically reduced.
  • the nucleotide sequence in the DNA molecule is at least 70% identical to the nucleotide sequence the expression of which is reduced, more specifically it is at least 80% identical, yet more specifically at least 90% identical, yet more specifically at least 95% identical, yet more specifically at least 99% identical.
  • a DNA molecule is inserted into a chromosomal copy of a nucleotide sequence of the present invention, or into a regulatory region thereof.
  • a DNA molecule comprises a transposable element capable of transposition in a plant cell, such as e.g. Ac/Ds, Em/Spm, mutator.
  • the DNA molecule comprises a T- DNA border of an Agrobacterium T-DNA.
  • the DNA molecule may also comprise a recombinase or integrase recognition site which can be used to remove part of the DNA molecule from the chromosome of the plant cell.
  • a mutation of a nucleic acid molecule of the present invention is created in the genomic copy of the sequence in the cell or plant by deletion of a portion of the nucleotide sequence or regulator sequence.
  • Methods of deletion mutagenesis are known to those skilled in the art. See, for example, Miao et al, (1995) Plant J. 7:359.
  • this deletion is created at random in a large population of plants by chemical mutagenesis or irradiation and a plant with a deletion in a gene of the present invention is isolated by forward or reverse genetics. Irradiation with fast neutrons or gamma rays is known to cause deletion mutations in plants (Silverstone et al, (1998) Plant Cell, 10:155-169; Bruggemann et al., (1996) Plant J., 10:755-760; Redei and Koncz in Methods in Arabidopsis Research, World Scientific Press (1992), pp. 16-82).
  • Deletion mutations in a gene of the present invention can be recovered in a reverse genetics strategy using PCR with pooled sets of genomic DNAs as has been shown in C. elegans (Liu et al., (1999), Genome Research, 9:859-867.).
  • a forward genetics strategy would involve mutagenesis of a line displaying PTGS followed by screening the M2 progeny for the absence of PTGS. Among these mutants would be expected to be some that disrupt a gene of the present invention. This could be assessed by Southern blot or PCR for a gene of the present invention with genomic DNA from these mutants.
  • nucleotide sequence of the present invention encoding a polypeptide is over-expressed.
  • nucleic acid molecules and expression cassettes for over-expression of a nucleic acid molecule of the present invention are described above. Methods known to those skilled in the art of over-expression of nucleic acid molecules are also encompassed by the present invention.
  • the expression of the nucleotide sequence of the present invention is altered in every cell of a plant. This is for example obtained though homologous recombination or by insertion in the chromosome. This is also for example obtained by expressing a sense or antisense RNA, zinc finger protein or ribozyme under the control of a promoter capable of expressing the sense or antisense RNA, zinc finger protein or ribozyme in every cell of a plant. Constitutive expression, inducible, tissue-specific or developmentally-regulated expression are also within the scope of the present invention and result in a constitutive, inducible, tissue- specific or developmentally-regulated alteration of the expression of a nucleotide sequence of the present invention in the plant cell.
  • Constructs for expression of the sense or antisense RNA, zinc finger protein or ribozyme, or for over-expression of a nucleotide sequence of the present invention are prepared and transformed into a plant cell according to the teachings of the present invention, e.g. as described infra. VII. Polypeptides
  • the present invention further relates to isolated polypeptides comprising the amino acid sequence of SEQ ID NO:2.
  • isolated polypeptides comprising the amino acid sequence of SEQ ID NO:2, and variants having conservative amino acid modifications.
  • conservative amino acid modifications One skilled in the art will recognize that individual substitutions, deletions or additions to a nucleic acid, peptide, polypeptide or protein sequence which alters, adds or deletes a single amino acid or a small percent of amino acids in the encoded sequence is a "conservative modification" where the modification results in the substitution of an amino acid with a chemically similar amino acid.
  • Conservative modified variants provide similar biological activity as the unmodified polypeptide.
  • Conservative substitution tables listing functionally similar amino acids are known in the art. See Crighton (1984) Proteins, W.H. Freeman and Company.
  • a polypeptide having substantial similarity to a polypeptide sequence of SEQ ID NO:2, or exon or domain thereof is an allelic variant of the polypeptide sequence listed in SEQ ID NO:2.
  • a polypeptide having substantial similarity to a polypeptide sequence listed in SEQ ID NO:2, or exon or domain thereof is a naturally occurring variant of the polypeptide sequence listed SEQ ID NO:2.
  • a polypeptide having substantial similarity to a polypeptide sequence listed SEQ ID NO:2, or exon or domain thereof is a polymorphic variant of the polypeptide sequence listed in SEQ ID NO:2.
  • the sequence having substantial similarity contains a deletion or insertion of at least one amino acid.
  • the deletion or insertion is of less than about ten amino acids. In a most specific embodiment, the deletion or insertion is of less than about three amino acids.
  • sequence having substantial similarity encodes a substitution in at least one amino acid.
  • sequence having substantial similarity encodes a substitution in at least one amino acid.
  • embodiments of the present invention also contemplate an isolated polypeptide containing a polypeptide sequence including
  • polypeptide sequence having substantial similarity (b) a polypeptide sequence having substantial similarity to (a); (c) a polypeptide sequence encoded by a nucleotide sequence identical to or having substantial similarity to a nucleotide sequence listed in SEQ ID NO:1 , or an exon or domain thereof, or a sequence complementary thereto;
  • the polypeptide having substantial similarity is an allelic variant of a polypeptide sequence listed in SEQ ID NO:2, or a fragment, domain, repeat or chimeras thereof.
  • the isolated nucleic acid includes a plurality of regions from the polypeptide sequence encoded by a nucleotide sequence identical to or having substantial similarity to a nucleotide sequence listed in SEQ ID NO:1 , or fragment or domain thereof, or a sequence complementary thereto.
  • the polypeptide is a polypeptide sequence listed in SEQ ID NO:2. In another specific embodiment, the polypeptide is a functional fragment or domain. In yet another specific embodiment, the polypeptide is a chimera, where the chimera may include functional protein domains, including domains, repeats, post-translational modification sites, or other features. In a more specific embodiment, the polypeptide is a plant polypeptide. In a more specific embodiment, the plant is a dicot. In a more specific embodiment, the plant is a gymnosperm. In a more specific embodiment, the plant is a monocot. In a more specific embodiment, the monocot is a cereal.
  • the cereal may be, for example, maize, wheat, barley, oats, rye, millet, sorghum, triticale, secale, einkorn, spelt, emmer, teff, milo, flax, gramma grass, Tripsacum, and teosinte.
  • the cereal is rice.
  • the polypeptide is expressed in a specific location or tissue of a plant.
  • the location or tissue is for example, but not limited to, epidermis, vascular tissue, meristem, cambium, cortex or pith.
  • the location or tissue is leaf or sheath, root, flower, and developing ovule or seed.
  • the location or tissue may be, for example, epidermis, root, vascular tissue, meristem, cambium, cortex, pith, leaf, and flower.
  • the location or tissue is a seed.
  • the polypeptide sequence encoded by a nucleotide sequence having substantial similarity to a nucleotide sequence listed in SEQ ID NO:1 or a fragment or domain thereof or a sequence complementary thereto includes a deletion or insertion of at least one nucleotide. In a more specific embodiment, the deletion or insertion is of less than about thirty nucleotides. In a most specific embodiment, the deletion or insertion is of less than about five nucleotides. In a specific embodiment, the polypeptide sequence encoded by a nucleotide sequence having substantial similarity to a nucleotide sequence listed in SEQ ID NO:1 , or fragment or domain thereof or a sequence complementary thereto, includes a substitution of at least one codon.
  • the substitution is conservative.
  • the polypeptide sequences having substantial similarity to the polypeptide sequence listed in SEQ ID NO:2, or a fragment, domain, repeat or chimeras thereof includes a deletion or insertion of at least one amino acid.
  • polypeptides of the invention, fragments thereof or variants thereof can comprise any number of contiguous amino acid residues from a polypeptide of the invention, wherein the number of residues is selected from the group of integers consisting of from 10 to the number of residues in a full- length polypeptide of the invention.
  • the portion or fragment of the polypeptide is a functional protein.
  • the present invention includes active polypeptides having specific activity of at least 20%, 30%, or 40%, and specifically at least 505, 60%, or 70%, and most specifically at least 805, 90% or 95% that of the native (non-synthetic) endogenous polypeptide.
  • the substrate specificity is optionally substantially similar to the native (non-synthetic), endogenous polypeptide.
  • Km will be at least 30%, 40%, or 50% of the native, endogenous polypeptide; and more specifically at least 605, 70%, 80%, or 90%.
  • the isolated polypeptides of the present invention will elicit production of an antibody specifically reactive to a polypeptide of the present invention when presented as an immunogen. Therefore, the polypeptides of the present invention can be employed as immunogens for constructing antibodies immunoreactive to a protein of the present invention for such purposes, but not limited to, immunoassays or protein purification techniques. Immunoassays for determining binding are well known to those of skill in the art such as, but not limited to, ELISAs or competitive immunoassays.
  • Embodiments of the present invention also relate to chimeric polypeptides encoded by the isolated nucleic acid molecules of the present disclosure including a chimeric polypeptide containing a polypeptide sequence encoded by an isolated nucleic acid containing a nucleotide sequence including: (a) a nucleotide sequence listed in SEQ ID NO:1 , or an exon or domain thereof;
  • the isolated nucleic acid molecules of the present invention are useful for expressing a polypeptide of the present invention in a recombinantly engineered cell such as a bacteria, yeast, insect, mammalian or plant cell.
  • a recombinantly engineered cell such as a bacteria, yeast, insect, mammalian or plant cell.
  • the cells produce the polypeptide in a non-natural condition (e.g. in quantity, composition, location and/or time) because they have been genetically altered to do so.
  • a non-natural condition e.g. in quantity, composition, location and/or time
  • nucleic acids encoding a polypeptide of the invention will typically be achieved, for example, by operably linking the nucleic acid or cDNA to a promoter (constitutive or regulatable) followed by incorporation into an expression vector.
  • the vectors are suitable for replication and/or integration in either prokaryotes or eukaryotes.
  • Commonly used expression vectors comprise transcription and translation terminators, initiation sequences and promoters for regulation of the expression of the nucleic acid molecule encoding the polypeptide.
  • expression vectors comprising a strong promoter to direct transcription, a ribosome binding site for translation initiation, and a transcription/translation terminator.
  • modifications may be made to the polypeptide of the present invention without diminishing its biological activity. Some modifications may be made to facilitate the cloning, expression or incorporation of the polypeptide of the invention into a fusion protein. Such modification are well known in the art and include, but are not limited to, a methionine added at the amino terminus to provide an initiation site, or additional amino acids (e.g. poly Histadine) placed on either terminus to create conveniently located purification sequences. Restriction sites or termination codons can also be introduced into the vector.
  • the expression vector includes one or more elements such as, for example, but not limited to, a promoter-enhancer sequence, a selection marker sequence, an origin of replication, an epitope- tag encoding sequence, or an affinity purification-tag encoding sequence.
  • the promoter-enhancer sequence may be, for example, the CaMV 35S promoter, the CaMV 19S promoter, the tobacco PR- la promoter, the ubiquitin promoter, and the phaseolin promoter.
  • the promoter is operable in plants, and more specifically, a constitutive or inducible promoter.
  • the selection marker sequence encodes an antibiotic resistance gene.
  • the epitope-tag sequence encodes V5, the peptide Phe- His-His-Thr-Thr, hemagglutinin, or glutathione-S-transferase.
  • the affinity purification-tag sequence encodes a polyamino acid sequence or a polypeptide.
  • the polyamino acid sequence is polyhistidine.
  • the polypeptide is chitin binding domain or glutathione-S-transferase.
  • the affinity purification-tag sequence comprises an intein encoding sequence.
  • Prokaryotic cells may be used a host cells, for example, but not limited to, Escherichia coli, and other microbial strains known to those in the art. Methods for expressing proteins in prokaryotic cells are well known to those in the art and can be found in many laboratory manuals such as Molecular Cloning: A Laboratory Manual, by J. Sambrook et al. (1989, Cold Spring Harbor Laboratory Press). A variety of promoters, ribosome binding sites, and operators to control expression are available to those skilled in the art, as are selectable markers such as antibiotic resistance genes. The type of vector chosen is to allow for optimal growth and expression in the selected cell type.
  • yeast eukaryotic expression systems
  • yeast insect cell lines, plant cells and mammalian cells.
  • Expression and synthesis of heterologous proteins in yeast is well known (see Sherman et al., Methods in Yeast Genetics, Cold Spring Harbor Laboratory Press, 1982).
  • yeast strains widely used for production of eukaryotic proteins are Saccharomyces cerevisiae and Pichia pastoris, and vectors, strains and protocols for expression are available from commercial suppliers (e.g., Invitrogen).
  • Mammalian cell systems may be transfected with expression vectors for production of proteins.
  • Many suitable host cell lines are available to those in the art, such as, but not limited to the HEK293, BHK21 and CHO cells lines.
  • Expression vectors for these cells can include expression control sequences such as an origin of replication, a promoter, (e.g., the CMV promoter, a HSV tk promoter or phosphoglycerate kinase (pgk) promoter), an enhancer, and protein processing sites such as ribosome binding sites, RNA splice sites, polyadenylation sites, and transcription terminator sequences.
  • Other animal cell lines useful for the production of proteins are available commercially or from depositories such as the American Type Culture Collection.
  • Expression vectors for expressing proteins in insect cells are usually derived from the SF9 baculovirus or other viruses known in the art.
  • suitable insect cell lines are available including but not limited to, mosquito larvae, silkworm, armyworm, moth and Drosophila cell lines.
  • Methods of transfecting animal and lower eukaryotic cells are known. Numerous methods are used to make eukaryotic cells competent to introduce DNA such as but not limited to: calcium phosphate precipitation, fusion of the recipient cell with bacterial protoplasts containing the DNA, treatment of the recipient cells with liposomes containing the DNA, DEAE dextrin, electroporation, biolistics, and microinjection of the DNA directly into the cells. Transfected cells are cultured using means well known in the art (see, Kuchler, R.J., Biochemical Methods in Cell Culture and Virology, Dowden, Hutchinson and Ross, Inc. 1997).
  • polypeptide of the present invention may be isolated and purified from the cells using methods known to those skilled in the art.
  • the purification process may be monitored using Western blot techniques or radioimmunoassay or other standard immunoassay techniques. Protein purification techniques are commonly known and used by those in the art (see R. Scopes, Protein Purification: Principles and Practice, Springer- Verlag, New York 1982: Lieber, Guide to Protein Purification, Academic Press (1990).
  • Embodiments of the present invention provide a method of producing a recombinant protein in which the expression vector includes one or more elements including a promoter-enhancer sequence, a selection marker sequence, an origin of replication, an epitope-tag encoding sequence, and an affinity purification-tag encoding sequence.
  • the nucleic acid construct includes an epitope-tag encoding sequence and the isolating step includes use of an antibody specific for the epitope-tag.
  • the nucleic acid construct contains a polyamino acid encoding sequence and the isolating step includes use of a resin comprising a polyamino acid binding substance, specifically where the polyamino acid is polyhistidine and the polyamino binding resin is nickel-charged agarose resin.
  • the nucleic acid construct contains a polypeptide encoding sequence and the isolating step includes the use of a resin containing a polypeptide binding substance, specifically where the polypeptide is a chitin binding domain and the resin contains chitin-sepharose.
  • polypeptides of the present invention cam be synthesized using non-cellular synthetic methods known to those in the art. Techniques for solid phase synthesis are described by Barany and Mayfield, Solid-Phase Peptide Synthesis, pp. 3-284 in the Peptides: Analysis, Synthesis, Biology, Vol.2, Special Methods in Peptide Synthesis, Part A; Merrifield, et al., J. Am. Chem. Soc. 85:2149-56 (1963) and Stewart et al., Solid Phase Peptide Synthesis, 2nd ed. Pierce Chem. Co., Rockford, IL (1984).
  • the present invention further provides a method for modifying (i.e. increasing or decreasing) the concentration or composition of the polypeptides of the invention in a plant or part thereof. Modification can be effected by increasing or decreasing the concentration and/or the composition (i.e. the ratio of the polypeptides of the present invention) in a plant.
  • the method comprised introducing into a plant cell with an expression cassette comprising a nucleic acid molecule of the present invention, or a nucleic acid encoding a OsGATA11 sequence as described above to obtain a transformed plant cell or tissue, culturing the transformed plant cell or tissue.
  • the nucleic acid molecule can be under the regulation of a constitutive or inducible promoter.
  • the method can further comprise inducing or repressing expression of a nucleic acid molecule of a sequence in the plant for a time sufficient to modify the concentration and/or composition in the plant or plant part.
  • a plant or plant part having modified expression of a nucleic acid molecule of the invention can be analyzed and selected using methods known to those skilled in the art such as, but not limited to, Southern blot, DNA sequencing, or PCR analysis using primers specific to the nucleic acid molecule and detecting amplicons produced therefrom.
  • concentration or composition in increased or decreased by at least 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80% or 90% relative to a native control plant, plant part or cell lacking the expression cassette.
  • Sugars are central regulators of many vital processes in photosynthetic plants, such as photosynthesis, carbon and nitrogen metabolism and this regulation is achieved by regulating gene expression, either activate or repress genes involved.
  • This GATA transcription factor disclosed here is involved in regulating sugar sensing and the expression of the factor itself is influenced by the change of the N status. Increased expression of this gene can produce plants with increased yield, particularly as the manipulation of sugar signaling pathways can lead to increased photosynthesis and increased nitrogen utilization and alter source-sink relationships in seeds, tubes, roots and other storage organs.
  • EXPERIMENTAL BACKGROUND AND PROCEDURES A Determining rice and maize growth conditions under limiting nitrogen conditions
  • the present inventors and others have utilized growth conditions in which nitrate was generally either present in excess or absent in its entirety. In the latter case, nitrate is typically added to plants grown in its absence in order to understand nitrate regulation of these and other genes. While this type of extreme treatment is useful in defining some aspects of gene regulation, it is not suitable to gain a better understanding of the effect of nitrogen limitation.
  • the inventors have defined conditions for Arabidopsis in which nitrogen limits growth (Bi et al 2007 BMC Genomics 8:281).
  • Transcript expression profiling can be used to test RNA levels of large numbers of genes at the same time. Large numbers of these types of experiments have been done in the past, and if the experimental system is amenable, these can be used to pinpoint the "expression status" of an organism under different conditions and to use this information to make hypotheses on what genes and pathways are involved in various processes. The inventors found that the more profound the difference in growth conditions, the larger the differences in transcript profiles between the plants grown under these conditions and the more difficult it was to decipher which changes were most important. The only published whole genome profiling experiment in this area is one in Arabidopsis where an extreme change in nitrate levels was studied (Wang R et al 2003 Plant Physiol. 132, 556-67). In the case of nitrogen limitations, the inventors studied the effect of growing plants under chronic nitrogen stress as well as changes in the level of available nitrogen. The inventors have already determined the impact on growth of different nitrogen levels in Arabidopsis.
  • Peat moss and vermiculate (1 :4) (SunGro Horticulture Canada Ltd. BC, Canada) was used to grow Oryza sativa Kaybonnet plants, adding nutrient solution with different amount of nitrate once a week till harvest.
  • the nutrient solution contains 4 mM MgSO 4 , 5 mM KCI, 5 mM CaCI 2 , 1 mM KH 2 PO 4 , 0.1 mM Fe-EDTA, 0.5 mM MES (pH6.0), 9 ⁇ M MnSO 4 , 0.7 ⁇ M Zn SO 4 , 0.3 ⁇ M CuSO 4 , 46 ⁇ M NaB 4 O 7 and 0.2 ⁇ M (NH 4 ) 6 Mo 7 O 2 .
  • RNAi The constructs for over-expressing or silencing OsGATAH were made.
  • the sequence of the RNAi sequence is shown in SEQ ID NO:8.
  • the sequence of the construct containing the RNAi sequence as an inverted repeat separated by a stemloop structure is shown in SEQ ID NO:9.
  • T1 transgenic seeds over-expressing OsGATAH, and silencing OsGA TA11 (RNAi) were analyzed. Genotyping transgenic plants Leaf samples were grounded in 300 ⁇ l buffer (Strategic Diagnostics
  • Primers for OsGATA11 are 5'- CGTCGAGCACCAAGGGCAAATC-3' (SEQ ID NO:3) and 5'- GGATAGGGTCATGAGCAGCATGG-S' (SEQ ID NO:4).
  • Primers for OsTubulin are: 5'- AGGAGGATGCCGCTAACAACTTTG-3' (SEQ ID NO:5) and 5'- AAACAGCATTGGTGATTTCAGGC-3' (SEQ ID N0:6).
  • Total chlorophyll was measured either using the Minolta SPAD 502DL chlorophyll meter (Tokyo, Japan), or extracted by ethanol and measured by spectrophotometer according to Kirk (1968). Metabolite analysis.
  • Leaves from 4-wk-old wild type and transgenic plants grown under the limiting nitrogen condition (3mM) were harvested, frozen in liquid nitrogen, and stored at - 80 0 C for the following biochemical analysis.
  • Nitrate was extracted from the frozen leaves and assayed according to Clothern et al., (1975).
  • Total amino acids were extracted successively with 80%, 50%, 0% ethonal in HEPES-KOH buffer (pH 7.4), and the pooled supernatants were used for total amino acids assay as described by Rosen (1957).
  • To extract soluble proteins the frozen leaf power was suspended in 100 mM HEPES- KOH (pH 7.5) + 0.1% Triton X-100 buffer and centrifuged at 14,000 rpm for 10 min.
  • the strategy for initial genetic and phenotypic analysis involved growing 5 transgenic events from each construct under mainly limiting nitrogen (N) condition (- 18 plants). Also some plants were grown under sufficient N condition ( ⁇ 10 plants). PMI sticks were used for genotyping to detect the selectable marker PMI. Transgene expression levels were tested by semi-quantitative RT-PCR. Chlorophyll level, culm length, tiller number, panicle number, flowering time, seed yield and shoot biomass was recorded. Phenotypes of the OsGATAH over-expression plants
  • the OsGATAH gene shares ⁇ 34% similarity at protein level with the AtGATA gene ⁇ At4g26150, Figure 3).
  • Total chlorophyll levels were measured when the transgenic plants were about 4-wk-old under limiting N condition. At least two transgenic events (event 5 and 6) had significant higher chlorophyll content from the average of PMI positive plants (3-6 plants) compared to wild type control plants (6 plants) ( Figure 4A). Those transgenic plants did have elevated expression of the OsGATAH gene ( Figure 4B). To ensure that chlorophyll level can be affected by the expression levels of the OsGATAH gene, the transgenic RNAi OsGATAH plants were analyzed.
  • Modulation of the expression of the OsGATA11 gene affects the levels of glucose (Figure 8A), fructose (Figure 8B) and sucrose (Figure 8C), as well as the levels of nitrate ( Figure 9A), amino acid (9B) and protein (Figure 9C).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention porte sur un gène du facteur de transcription GATA régulé par l'azote, requis pour l'accumulation de sucre et d'azote, et sur la modulation de l'expression de ce gène pour moduler une caractéristique dans une plante. Le facteur de transcription GATA de la présente invention est mis en jeu dans la régulation de l'accumulation de sucre et d'azote dans les plantes. Une expression accrue de ce gène ou de gènes sensiblement similaires permet de produire des plantes avec une utilisation améliorée de l'azote, un rendement accru et une tolérance accrue au stress.
EP08733744A 2007-04-17 2008-04-16 Gene et proteine de regulation du carbone et de l'azote et modulation de ceux-ci Withdrawn EP2144996A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA 2584934 CA2584934A1 (fr) 2007-04-17 2007-04-17 Gene et proteine de detection de sucre regules par l'azote et modulation associee
PCT/CA2008/000688 WO2008124933A1 (fr) 2007-04-17 2008-04-16 Gène et protéine de régulation du carbone et de l'azote et modulation de ceux-ci

Publications (2)

Publication Number Publication Date
EP2144996A1 true EP2144996A1 (fr) 2010-01-20
EP2144996A4 EP2144996A4 (fr) 2010-06-09

Family

ID=39855358

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08733744A Withdrawn EP2144996A4 (fr) 2007-04-17 2008-04-16 Gene et proteine de regulation du carbone et de l'azote et modulation de ceux-ci

Country Status (9)

Country Link
EP (1) EP2144996A4 (fr)
CN (2) CN104726464A (fr)
AR (1) AR066094A1 (fr)
BR (1) BRPI0810652A2 (fr)
CA (1) CA2584934A1 (fr)
CL (1) CL2008001097A1 (fr)
MX (1) MX2009011184A (fr)
WO (1) WO2008124933A1 (fr)
ZA (1) ZA200907097B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101948870B (zh) * 2010-09-08 2012-06-27 上海交通大学 减少植物分枝数量和提高叶绿素和花色素苷含量的方法
CN107937415B (zh) * 2017-12-27 2020-04-07 宁夏农林科学院农业生物技术研究中心 一种马铃薯gata转录因子及其克隆方法与应用
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
CN116640769B (zh) * 2023-05-17 2024-08-20 青岛农业大学 花生AhGATA11基因及其在提高植物抗逆性中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031349A2 (fr) * 2002-09-18 2004-04-15 Mendel Biotechnology, Inc. Polynucleotides et polypeptides chez des plantes

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100792A (en) 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
EP0218571B1 (fr) 1985-08-07 1993-02-03 Monsanto Company Plantes résistant au glyphosate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
EP0846771A1 (fr) 1987-05-20 1998-06-10 Novartis AG Plantes de zea mays et plantes transgéniques de zea mays régénérées de protoplastes ou de cellules dérivées de protoplastes
ES2052772T3 (es) 1987-08-21 1994-07-16 Ciba Geigy Ag Procedimiento y agente contra enfermedades de plantas.
EP0332581B1 (fr) 1988-03-08 1996-12-11 Ciba-Geigy Ag Régénération de plantes graminées fertiles de la sous-famille des pooideae à partir de protoplastes
PT89915B (pt) 1988-03-08 1994-10-31 Ciba Geigy Ag Processo para a preparacao de sequencias de dna regulaveis quimicamente
US5614395A (en) 1988-03-08 1997-03-25 Ciba-Geigy Corporation Chemically regulatable and anti-pathogenic DNA sequences and uses thereof
CA1339684C (fr) 1988-05-17 1998-02-24 Peter H. Quail Systeme de collecte de l'ubiquitine vegetale
NZ230375A (en) 1988-09-09 1991-07-26 Lubrizol Genetics Inc Synthetic gene encoding b. thuringiensis insecticidal protein
ES2164633T3 (es) 1989-02-24 2002-03-01 Monsanto Technology Llc Genes vegetales sinteticos y procedimiento para su preparacion.
DK0392225T3 (da) 1989-03-24 2003-09-22 Syngenta Participations Ag Sygdomsresistente transgene planter
US5501967A (en) 1989-07-26 1996-03-26 Mogen International, N.V./Rijksuniversiteit Te Leiden Process for the site-directed integration of DNA into the genome of plants
US4940935A (en) 1989-08-28 1990-07-10 Ried Ashman Manufacturing Automatic SMD tester
EP0452269B1 (fr) 1990-04-12 2002-10-09 Syngenta Participations AG Promoteurs à préférence tissulaire
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5639949A (en) 1990-08-20 1997-06-17 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
GB9304200D0 (en) 1993-03-02 1993-04-21 Sandoz Ltd Improvements in or relating to organic compounds
US5994629A (en) 1991-08-28 1999-11-30 Novartis Ag Positive selection
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
US5679558A (en) 1992-04-15 1997-10-21 Plant Genetic Systems, N.V. Transformation of monocot cells
US5591616A (en) 1992-07-07 1997-01-07 Japan Tobacco, Inc. Method for transforming monocotyledons
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
WO1995019431A1 (fr) 1994-01-18 1995-07-20 The Scripps Research Institute Derives de proteine a doigts zinciques et procedes associes
USRE45721E1 (en) 1994-08-20 2015-10-06 Gendaq, Ltd. Relating to binding proteins for recognition of DNA
CA2247074C (fr) 1996-02-28 2008-06-10 Novartis Ag Molecules d'adn codant pour la protoporphyrinogene-oxydase vegetale et mutants de cette enzyme resistants aux inhibiteurs
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
EP2267138B1 (fr) 1998-04-08 2016-06-08 Commonwealth Scientific and Industrial Research Organization Procédés et moyens d'obtention de phénotypes modifiés
AR020078A1 (es) 1998-05-26 2002-04-10 Syngenta Participations Ag Metodo para alterar la expresion de un gen objetivo en una celula de planta
JP2005185101A (ja) * 2002-05-30 2005-07-14 National Institute Of Agrobiological Sciences 植物の全長ｃＤＮＡおよびその利用
MX2007008568A (es) 2005-01-14 2008-01-11 Univ Guelph Gen y proteina de deteccion de azucar regulados por nitrogeno y modulacion de los mismos.
US20070250956A1 (en) * 2005-01-14 2007-10-25 University Of Guelph Nitrogen-Regulated Sugar Sensing Gene and Protein and Modulation Thereof
WO2006089950A2 (fr) * 2005-02-26 2006-08-31 Basf Plant Science Gmbh Cassettes d'expression destinees a une expression preferentielle de semences chez des plantes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031349A2 (fr) * 2002-09-18 2004-04-15 Mendel Biotechnology, Inc. Polynucleotides et polypeptides chez des plantes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BI YONG-MEI ET AL: "Genetic analysis of Arabidopsis GATA transcription factor gene family reveals a nitrate-inducible member important for chlorophyll synthesis and glucose sensitivity" PLANT JOURNAL, vol. 44, no. 4, November 2005 (2005-11), pages 680-692, XP002577364 ISSN: 0960-7412 *
See also references of WO2008124933A1 *

Also Published As

Publication number Publication date
EP2144996A4 (fr) 2010-06-09
CA2584934A1 (fr) 2008-10-17
BRPI0810652A2 (pt) 2014-10-07
ZA200907097B (en) 2016-08-31
AR066094A1 (es) 2009-07-22
CN101688180A (zh) 2010-03-31
MX2009011184A (es) 2009-11-02
CL2008001097A1 (es) 2008-08-22
WO2008124933A1 (fr) 2008-10-23
CN104726464A (zh) 2015-06-24

Similar Documents

Publication Publication Date Title
AU2003299859B2 (en) Stress-related polypeptides and uses therefor
US20100218282A1 (en) Nucleic acid molecules from rice controlling abiotic stress tolerance
WO2005084331A2 (fr) Établissement de profils du gène de sorgho
WO2003048319A2 (fr) Molecules d'acide nucleique a partir de riz codant des proteines pour la tolerance au stress abiotique, un meilleur rendement, une resistance a la maladie, et une qualite nutritionnelle modifiee, et utilisations correspondantes
US8586825B2 (en) Nitrogen-regulated sugar sensing gene and protein and modulation thereof
US20090328255A1 (en) Nitrogen limitation adaptability gene and protein and modulation thereof
US8742201B2 (en) Nitrogen-regulated sugar sensing gene and protein and modulation thereof
US20070294789A1 (en) Photoperiodic control of floret differentiation and yield in plants
WO2008124933A1 (fr) Gène et protéine de régulation du carbone et de l'azote et modulation de ceux-ci
US6956115B2 (en) Nucleic acid molecules from rice encoding RAR1 disease resistance proteins and uses thereof
US7230159B2 (en) Isolated BOS1 gene promoters from arabidopsis and uses thereof
WO2007060514A2 (fr) Procedes et compositions pour moduler la croissance des racines de plantes
WO2007036045A1 (fr) Procede pour moduler le temps de floraison et la ramification de pousses
WO2005014794A2 (fr) Production de plantes a faible teneur en phytate par rupture moleculaire des inositol polyphosphate kinases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100512

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20121031

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSITY OF GUELPH

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/82 20060101ALI20150911BHEP

Ipc: G01N 33/68 20060101AFI20150911BHEP

Ipc: G01N 33/50 20060101ALI20150911BHEP

INTG Intention to grant announced

Effective date: 20151012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160223